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Abstract 
 
Lipoteichoic acid (LTA) is an important polymer present in the envelope of 
various Gram-positive bacteria. In Staphylococcus aureus it is composed of a 
polyglycerolphosphate chain synthesised by the enzyme LtaS, and is anchored to the 
membrane via a glycolipid anchor. Depletion of LTA is known to cause growth arrest, 
aberrant positioning of septa and enlargement of cells leading to eventual cell lysis. This 
highlights the importance of LTA for bacterial growth and also suggests a possible link 
between LTA synthesis and cell division. Although key enzymes required for LTA 
synthesis have been identified, how this process is regulated has not been elucidated. 
This study investigates the mechanisms of regulation of LTA synthesis, as well as 
provides further insights into the roles of LTA in S. aureus.  
 In this study, nuclear magnetic resonance (NMR) was used to experimentally 
confirm a function for LTA in the incorporation of D-alanines into a second polymer, 
wall teichoic acid (WTA). LTA was also shown to be essential not only for bacterial 
growth, but also for bacterial survival, as cells become bactericidal in its absence. 
Furthermore, fluorescence microscopy using a GFP-tagged version of the synthase 
enzyme indicated that LtaS localises to the septum, suggesting a possible role for LTA 
in cell division.  
 Regarding LTA regulation, this work has shown that the ltaS gene has two 
promoters and a large upstream UTR, but that only one promoter is essential and 
sufficient for expression. Studying the effect of salt stress on LTA production has also 
revealed that an increase the NaCl concentration in the media causes a reduction in the 
levels of LTA produced, which in turn has an effect on growth. However this is not due 
to a decrease in the levels of LtaS, reflecting a possible ionic or osmotic effect on LtaS 
enzymatic activity.  
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Resumo 
 
 O ácido lipoteicóico (LTA) é um importante polímero presente no envelope de 
varias bactérias Gram-positivas. Em Staphylococcus aureus é composto por uma cadeia 
de poliglicerolfosfato sintetizada pela enzima LtaS e está ancorado na membrana 
através de uma âncora glicolipídica. Sabe-se que na ausência de LTA há interrupção do 
crescimento bacteriano, o septo deslocaliza e as células aumentam o seu tamanho e 
eventualmente lisam. Estas observações, mostram a importância do LTA para o 
crescimento bacteriano e sugerem uma ligação entre a sua síntese e a divisão celular. 
Apesar das principais enzimas necessárias para a síntese de LTA serem conhecidas, a 
regulação deste processo permanece por elucidar. Este estudo investiga a regulação da 
síntese do LTA e fornece novas perspectivas sobre as suas funções em S. aureus.  
 Neste estudo, ressonância magnética nuclear foi utilizada para confirmar 
experimentalmente a função do LTA na incorporação de D-alanina num segundo 
polímero, o ácido teicóico da parede (WTA). Mostrou-se também que o LTA não só é 
essencial para o crescimento, mas também para a sobrevivência bacteriana, tendo a sua 
ausência um efeito bactericida. Adicionalmente, microscopia de fluorescência utilizando 
fusões da sintase à proteína de fluorescência GFP, demonstrou que LtaS localiza no 
septo, sugerindo uma possível função do LTA na divisão celular. 
Relativamente à regulação da produção de LTA, este trabalho mostrou que o 
gene ltaS tem dois promotores e uma grande região não traduzida a montante, mas 
apenas um dos promotores é essencial e suficiente para ocorrer expressão. O estudo do 
efeito do aumento da salinidade na produção de LTA mostrou que o aumento da 
concentração de NaCl causa uma redução nos níveis de LTA, causando uma redução no 
crescimento. No entanto, esta observação não se deve a uma diminuição nos níveis de 
LtaS, reflectindo um possível efeito iónico ou osmótico na actividade enzimática de 
LtaS.  
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 1 
1. Introduction 
 
1.1. Staphylococcus aureus 
 
 
Staphylococcus aureus is a Gram-positive bacterium that is able to colonise and 
infect human and animal hosts. It is non-motile, non-sporeforming, facultative anaerobe 
and a member of the Firmicutes that is distinguishable from other staphylococcal 
species by its ability to produce coagulase (coagulase-positive), a secreted protein that 
promotes clumping of the human blood cell (Gotz et al., 2006). S. aureus cells are 0.5-
1.5 μm in diameter and can occur in various forms: singly, in pairs, tetrads or as grape-
like clusters, which are formed by cells that fail to fully separate (Gotz et al., 2006; 
Tzagoloff & Novick, 1977). Cell division occurs in three orthogonal planes and the 
future cell division site is perpendicular to the previous septum (Tzagoloff & Novick, 
1977).  
On agar plates S. aureus forms golden-yellow round colonies, which is due to its 
ability to produce a carotenoid pigment, staphyloxanthin, that is important for its 
virulence and to evade the host innate immune system (Liu et al., 2005). Like other 
staphylococcal species, it has a low guanine and cytosine content in its genome (30-39 
mol %) and the genome is approximately 3000 kb in size (Gotz et al., 2006).  
S. aureus mainly colonises the nasal passages transiently, sometimes 
permanently, and is a potential pathogen, which is able to cause both superficial skin 
infections as well as invasive infections such as toxic shock syndrome, endocarditis and 
osteomyelitis (Foster, 2005; Lowy, 2003).  
The introduction of penicillin in the 1940s quickly promoted the proliferation of 
resistant S. aureus strains expressing β-lactamase (Barber & Rozwadowska-Dowzenko, 
1948), making the development of antibiotics against this Gram-positive pathogen a 
challenge. β-lactamase is encoded by blaZ that is part of a transposable element in a 
large plasmid. This enzyme acts by hydrolysing the β-lactam ring inactivating the 
antibiotic (Bondi & Dietz, 1945; Rowland & Dyke, 1989). With the introduction in the 
1950s of the first semisynthetic penicillin, methicillin, methicillin-resistant S. aureus 
(MRSA) became a concern and the foremost cause of bacterial infections at a global 
scale (Fuda et al., 2005). MRSA strains were initially found to be hospital associated 
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(HA-MRSA), where the majority of infections still occur, but nowadays it is also 
community associated (CA-MRSA) (Fey et al., 2003; Okuma et al., 2002). β-lactam 
antibiotics act by mimicking the substrate of penicillin-binding proteins (PBPs) and, 
consequently, acylate and inactivate the PBPs, which are essential for the last steps of 
peptidoglycan synthesis (Chambers, 2003). The resistance mechanism in MRSA strains 
is due to the acquisition of an extra PBP, PBP2A encoded by the mecA gene (Beck et 
al., 1986). This PBP is able to perform the normal functions of the other PBPs in cell 
wall biosynthesis, but has low affinity for all β-lactam antibiotics (Beck et al., 1986; de 
Jonge et al., 1992). PBP2A acts by compensating for PBP2 transpeptidase (TPase) 
function, though the transglycosylase (TGase) function of PBP2 is still required (Pinho 
et al., 2001) (see section 1.2.2. Peptidoglycan structure and synthesis).  
The glycopeptide antibiotic vancomycin started to be used as an alternative 
treatment for MRSA infections. However, vancomycin-intermediate S. aureus (VISA) 
and fully vancomycin-resistant S. aureus (VRSA) have now been already detected. In 
VISA strains there is an increase in the quantity of peptidoglycan, which results in an 
increase of D-Ala-D-Ala residues exposed and, since these are the targets for 
vancomycin, the access to the bacterial target is prevented (Sieradzki & Tomasz, 1999). 
VRSA strains, on the other hand, emerged due to the acquisition of the vanA gene from 
vancomycin resistant enterococci. In these isolates, the terminal dipeptide in the 
peptidoglycan is D-Ala-D-Lac instead of D-Ala-D-Ala, the synthesis of which is 
catalysed by a ligase encoded by vanA (Showsh et al., 2001).  
Given the emergence of resistance mechanisms to the available antibiotics, there 
has been a growing interest in studying the staphylococcal cell surface in order to find 
novel antibiotic targets.  
 
1.2. Components of the S. aureus cell wall 
 
The wall of Gram-positive bacteria is characterised by a thick layer of cross-
linked peptidoglycan (PGN) that enables these bacteria to survive in harsh 
environments, even lacking the outer membrane characteristic of Gram-negative 
bacteria (Silhavy et al., 2010) (Figure 1). Besides peptidoglycan other components are 
required to maintain the envelope structure and function, including the teichoic acids 
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(TAs). TAs are composed of polyol-phosphate subunits and can be grouped into wall 
teichoic acids (WTAs), which are covalently attached to the peptidoglycan and 
lipoteichoic acids (LTAs), which are anchored to the cell membrane via a glycolipid 
anchor (Fischer, 1994; Neuhaus & Baddiley, 2003; Reichmann & Gründling, 2011; Xia 
et al., 2010) (Figure 1). 
 The surface of Gram-positive bacteria also contains proteins that can be 
associated with the membrane through membrane spanning domains or attached to lipid 
anchors (Silhavy et al., 2010). Proteins can also be associated to the peptidoglycan 
layers or to other polymers such as TAs and polysaccharides (Navarre & Schneewind, 
1999) (Scott & Barnett, 2006). It is still worth noting that the presence of a low-density 
region that can be considered to be the Gram-positive periplasm has been identified in 
these bacteria (Matias & Beveridge, 2005; Matias & Beveridge, 2006; Matias & 
Beveridge, 2008) (Figure 1). 
The membrane is a phospholipidic bilayer with integrated membrane proteins 
and other components such as LTA and lipoproteins. In S. aureus, the four major lipids 
making up the membrane are diglucosyl diacylglycerol (Glc2-DAG), phosphatidyl 
glycerol (PG), diacylglycerol (DAG) and a lysyl-phosphatidyl glycerol (Lys-PG) (Koch 
et al., 1984; White & Frerman, 1967). LTA represents 6% of the membrane 
composition and its synthesis is closely interconnected with the synthesis of the other 
membrane lipids (Koch et al., 1984) (see section 1.2.3.2 LTA structure and synthesis). 
In the majority of the S. aureus strains there is also a polysaccharide capsule 
external to the peptidoglycan layer that has been shown to be important for virulence, 
colonisation and biofilm formation (O'Riordan & Lee, 2004).  
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Figure 1 – Schematic representation of the cell wall in Gram-positive bacteria. The cell wall in 
Gram-positive bacteria is mainly composed of cross-linked peptidoglycan (blue hexagons), teichoic acids 
that can be divided into wall teichoic acids (WTAs) (green circles) and lipoteichoic acids (LTAs) (pink 
circles). Additionally, there are proteins associated to the membrane or to the peptidoglycan layer 
(purple). Adapted from Reichmann and Gründling, 2011.   
 
1.2.1. The polysaccharide capsule  
 
A capsule usually surrounds microorganisms that cause invasive infections. 
Encapsulation is an important characteristic as it enhances virulence and protects the 
bacteria from phagocytic uptake (O'Riordan & Lee, 2004). In S. aureus, polysaccharide 
capsules are grouped into serotypes and, although there are 11 serotypes, the serotype 5 
and 8 are the most predominant ones in clinical isolates (Hochkeppel et al., 1987; 
Roghmann et al., 2005; Sompolinsky et al., 1985). 
Of the S. aureus strains where the capsule biochemical structure has been 
ascertained all contain hexosaminuronic acids. Although types 5 and 8 belong to 
different serotypes, they have similar structures: both have a residue of N-
acetylmannosaminuronic acid (ManNAcA) and two residues of N-acetyl-L-fucosamine 
(FucNAc) and they only differ in the way the sugars are linked and in the site of O-
acetylation of the N-acetylamannosaminuronic acid residues (Fournier et al., 1984; 
Fournier et al., 1987). 
The proteins required for the synthesis of serotypes 5 and 8 capsules are encoded 
in the gene clusters cap5 and cap8, respectively. These clusters contain homologous 
genes (cap5A, cap5G and cap5L-P are very similar to cap8A, cap8G and cap8L-P) but 
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also contain type-specific genes. The functions of these genes have not been 
experimentally demonstrated but the majority are likely to be involved in sugar 
synthesis, transfer, chain-length regulation and polymerisation (Sau et al., 1997). 
It has been shown that the environment has an influence on polysaccharide 
capsule production. For example, growth in low concentrations of iron and on solid 
medium enhances the production of the serotype 8 capsule (Lee et al., 1993; Poutrel et 
al., 1995). Furthermore, serotype 5 capsule production is downregulated by CO2 levels 
(serotype 8 capsule production is also regulated by CO2 levels but in a genetic 
background dependent manner between different strains) and enhanced by NaCl 
concentration (Herbert et al., 2001; Sompolinsky et al., 1985). 
 
1.2.2. Peptidoglycan structure and synthesis  
 
The peptidoglycan structure is common to most bacteria, both Gram-positive 
and Gram-negative (Silhavy et al., 2010). It is composed of disaccharide-peptide 
repeats linked through glycolipid bonds [β-1,4 linkages between N-acetylmuramic acid 
(MurNAc) and N-acetylglucosamine (GlcNAc) subunits] forming glycan strands, which 
in turn are cross-linked through peptide stems attached to the MurNAc subunits 
(Ghuysen & Strominger, 1963; Navarre & Schneewind, 1999). This results in a 
structure that is flexible enough to ensure that the cell can resist changes in the internal 
osmotic pressure (Scheffers & Pinho, 2005). Although this structure is well dispersed 
amongst bacteria, its length is variable and in S. aureus most of the glycan strands have 
3 to 10 subunits, but can reach up to 26 subunits (Navarre & Schneewind, 1999; 
Scheffers & Pinho, 2005).  
The peptide stems also vary significantly, though they all consist of a 
pentapeptide chain containing L- and D-amino acids and one dibasic amino acid (L-
lysine in many Gram-positive bacteria), which allows the formation of the peptide cross 
bridge. In S. aureus, the pentapeptide is composed of L-alanine (L-Ala), D-glutamine (D-
Gln), L-lysine (L-Lys) and two D-alanine residues (D-Ala-D-Ala). The peptides are 
connected through a pentaglycine structure extending from the L-Lys residue and 
connecting it to the penultimate D-Ala residue in the neighbouring peptide (Navarre & 
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Schneewind, 1999). S. aureus has a high degree of cross-linking when compared with 
other Gram-positive bacteria (up to 90% comparing with 56 to 63% in B. subtilis, for 
example), which is mainly attributed to PBP4 (Scheffers & Pinho, 2005). 
    As described below, the biosynthesis of peptidoglycan can be divided into 
three stages: 
a) The first stage takes place in the cytoplasm and generates the precursors 
UDP-N-acetylmuramyl-pentapeptide (UDP-MurNAc-pentapeptide) and UDP-N-
acetylglucosamine (UDP-GlcNAc). These steps involve the GlmM, GlmS and GlmU 
and the MurA-F proteins in a well known pathway (reviewed in Barreteau et al., 2008).  
b) The second stage occurs in the cytoplasmic membrane, where precursor 
lipid intermediates are synthesised. Phospho-MurNAc-pentapeptide is transferred from 
UDP-MurNAc-pentapeptide to the membrane acceptor bactoprenol producing 
MurNAc-(pentapeptide)-pyrophosphoryl-undecaprenol, also called lipid I . The addition 
of GlcNAc to lipid I then yields GlcNAc-β-(1,4)-MurNAc-(pentapeptide)-
pyrophosphoryl-undecaprenol, commonly known as lipid II (Scheffers & Pinho, 2005). 
The five glycine residues involved in cross-linking are added to the L-Lys residue by the 
nonribosomal peptidyl transferases Fem A, Fem B and Fem X (Berger-Bachi & 
Tschierske, 1998; Ton-That et al., 1998). These precursors are then translocated across 
the hydrophobic membrane to the outer leaflet of the membrane prior to being 
incorporated into the growing peptidoglycan chains (Scheffers & Pinho, 2005). 
c) The last steps involve two reactions, transglycosylation and 
transpeptidation, which are catalysed by the PBPs (Sauvage et al., 2008). 
Transglycosylation is the transference of the C-4 carbon from the glucosamine residue 
of the lipid-linked precursor to the MurNAc of the nascent peptidoglycan with the 
release of undecaprenyl-pyrophosphate, leading to the incorporation of precursor 
subunits into the growing peptidoglycan strand (Scheffers & Pinho, 2005). The 
transpeptidation reaction leads to formation of peptide bonds between the peptide stems. 
Firstly, the D-Ala-D-Ala linkage is cleaved resulting in an enzyme-substrate 
intermediate with the PBP. This releases the energy necessary for the transfer of a 
peptidyl moiety to a glycine on the pentaglycine bridge of a neighbouring peptide stem, 
resulting in a cross-bridge between the peptidoglycan subunits (Scheffers & Pinho, 
2005). 
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In methicillin susceptible S. aureus strains (MSSA) there are four native PBPs, 
which catalyse these reactions. PBP1 has an essential role in cell division and its 
transpeptidase domain has been shown to play a vital role during cell separation 
(Pereira et al., 2009). PBP2 has both TGase and TPase activity and localises at the cell 
division site (Scheffers & Pinho, 2005). However, in the presence of oxacillin, a β-
lactam antibiotic which binds to the transpeptidase domain, PBP2 delocalises, 
indicating that binding to its substrate is necessary for correct localisation (Pinho & 
Errington, 2005). In methicillin resistant S. aureus strains there is an additional PBP, the 
PBP2A, which is encoded by the mecA gene (Beck et al., 1986; Hartman & Tomasz, 
1984) and is able to restore PBP2 localisation even in the presence of oxacillin (Pinho 
& Errington, 2005). This extra PBP acts as a surrogate for the TPase activity of PBP2 in 
the presence of β-lactam antibiotics, but the TGase activity of the native PBP2 is still 
needed (Pinho et al., 2001). PBP3 is encoded by pbpC and its absence does not cause a 
change in peptidoglycan composition. However, the mutant of PBP3, once grown in the 
presence of sub-MIC levels of methicillin, displays increased cell size, aberrant cell 
shape and misplacement of the septa, indicating a role in cell division (Pinho et al., 
2001). Finally, PBP4 is non-essential, is responsible for the high degree of 
peptidoglycan cross-linking observed in S. aureus and its mutant was found to be more 
susceptible to β-lactams (Memmi et al., 2008; Wyke et al., 1981).  
Besides the enzymes necessary for PG synthesis it is also important not to forget 
that PG hydrolases have a vital role in cell growth, since it is important to cleave old PG 
in order to incorporate new material. Therefore, it has been proposed that PG synthases 
form a multienzyme complex together with hydrolases in order to maintain the 
equilibrium between these two activities (Scheffers & Pinho, 2005).   
 
1.2.3. Teichoic acids 
  
The cell surface of most Gram-positive bacteria including S. aureus and B. 
subtilis also contain TAs. These components have a zwitterionic character and perform 
crucial roles in bacterial survival and cellular processes (Kohler et al., 2009; Xia et al., 
2010). TAs act as a layer of protection to the PG layer from small harmful molecules 
and other environmental stresses but, since these are the more external components (at 
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least in S. aureus), and given its charge distribution, they are also possibly involved in 
regulating cation concentrations and enzymatic activities at the cell surface and in 
mediating interactions with receptors and biomaterials, which is relevant in biofilm 
formation (Schirner et al., 2009; Weidenmaier & Peschel, 2008; Xia et al., 2010).  
TAs are composed of repeating polyol phosphate subunits such as ribitol 
phosphate (RboP) or glycerol phosphate (GroP) and can be grouped into WTA that is 
covalently linked to the peptidoglycan, and LTA that is anchored to the membrane 
through a glycolipid anchor and extends into the wall (Xia et al., 2010). 
 
1.2.3.1. WTA structure, synthesis and functions 
 
 WTA is structural diverse in Gram-positive bacteria due to the nature of its 
monomeric forms and to modifications with glycosyl substituents and D-alanyl esters 
(Neuhaus & Baddiley, 2003). The monomers are polyol phosphate residues, which form 
linear chains covalently linked to the peptidoglycan through a phosphodiester bond. In 
the majority of S. aureus strains, the chains consist of RboP subunits, while in B. 
subtilis WTA is made up of GroP residues (Bertram et al., 1981; Sanderson et al., 
1962). S. aureus WTA is  covalently linked to the C6 hydroxyl group of MurNAc of 
peptidoglycan, through a disaccharide, composed of N-acetylglucosamine-1-phosphate 
(GlcNAc-1-P) and N-acetylmannosamine (ManNAc), and two GroP residues (Figure 2) 
(Brown et al., 2008; Xia et al., 2010).  
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Figure 2 – WTA chemical structure in S. aureus. The RboP chain can be modified with a D-alanyl 
ester (blue) or glycosyl group (green) and is linked to the peptidoglycan via a disaccharide composed of 
N-acetylglucosamine-1-phosphate (GlcNAc-1-P) and N-acetylmannosamine (ManNAc), and two GroP 
residues (pink).  
 
 
The steps for S. aureus WTA synthesis are known and begin at the inner leaflet 
of the cytoplasmic membrane where the disaccharide linkage unit is produced. First, 
GlcNAc-1-P and ManNAc are transferred from UDP-activated precursor molecules to 
undecaprenylphosphate (C55-P), by TagO and TagA, respectively (Brown et al., 2008; 
Xia et al., 2010). This first step is followed by the addition of the GroP residues, 
involving TagB that adds the first GroP subunit to the disaccharidic linker, and TarF, 
which adds the second GroP subunit. The substrate used by these enzymes is the 
activated precursor cytidine diphosphoglycerol (CDP-Gro), which is generated by TagD 
(Badurina et al., 2003). TarL then polymerises the poly-RboP chain (Brown et al., 
2008), using as its substrate the TarIJ generated precursor, CDP-Rbo (Meredith et al., 
2008). Finally, this structure is transported to the outside of the cell through a two-
component transporter (TagG and TagH), where it can be attached to the peptidoglycan 
(Brown et al., 2008). Besides D-alanylation, S. aureus WTA is also modified with α- or 
β-O-acetylgucosamine residues, which are added due the action of TarM and TarS as 
recently shown (Brown et al., 2012).   
Although WTA is not essential for viability in both S. aureus and B. subtilis 
(D'Elia et al., 2006; Weidenmaier et al., 2004a), it has important roles in virulence. 
WTA protects the cell from the host immune defences such as lysozyme, possibly by 
preventing the enzyme from reaching the glycan strands of PG (Bera et al., 2007), and 
also from antimicrobial fatty acids due to its hydrophilic properties (Kohler et al., 2009), 
which makes WTA important for infection, especially for skin infection. Furthermore, 
WTA is important for adherence to epithelial and endothelial cells (Weidenmaier et al., 
2004a; Weidenmaier et al., 2005). These functions make WTA vital during host 
infection and colonisation. Besides this, WTA, being at the surface, is also important for 
phage binding, which makes it relevant for phage typing (Pantucek et al., 2004).  
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1.2.3.2. LTA structure and synthesis  
 
LTA consists of a polyglycerolphosphate (PGP) chain that is linked through a 
glycolipid anchor to the bacterial membrane and extends into the cell wall (Figure 3) 
(Archibald et al., 1968; Fischer, 1994). In staphylococci, bacilli and streptococci the 
glycolipid anchor is glucosyl (β1-6) glucosyl (β1-3) diacylglycerol (Glc2-DAG) 
(Neuhaus & Baddiley, 2003; Reichmann & Gründling, 2011). Although LTA has a 
well-defined structure there is still variability due to glycosyl and D-alanine 
substitutions, fatty acid composition and length of the PGP chain (Neuhaus & Baddiley, 
2003).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 – LTA chemical structure in S. aureus. The polyglycerolphosphate (PGP) chain is linked to 
the membrane through a glycolipid anchor (Glc2-DAG) (pink). The PGP chain can be modified at the C2 
position with D-alanine residues, as shown in blue. Adapted from Reichmann & Gründling, 2011. 
 
 
LTA synthesis can be mainly divided into three steps: the glycolipid anchor 
synthesis (Figure 4, steps 1 to 4), the PGP chain polymerization (Figure 4, step 5) and 
the addition of D-alanine residues (Figure 4, step 6) (Fischer, 1994). 
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Figure 4 – Schematic representation of LTA synthesis in S. aureus. The glycolipid anchor (orange) is 
synthesised in the cytoplasm of the cell by PgcA, GtaB and YpfP (blue) (steps 1 to 3), and translocated 
across the membrane, which possibly involves LtaA (violet) (step 4). The polyglycerolphosphate chain 
(pink circles) is synthesised by the LTA synthase, LtaS (dark blue) (step 5). The DltA-D proteins (green) 
(step 6) are essential for the incorporation of D-alanine esters (dark red) into the LTA chain.  
 
In S. aureus and B. subtilis, the Glc2-DAG anchor is synthesised in the 
cytoplasm and this process involves the transference of two glucose moieties from 
uridine diphosphate glucose (UDP-Glc) to DAG (Fischer, 1994; Kiriukhin et al., 2001) 
(Figure 4). For this to occur, the action of three enzymes is required: PgcA (or Pgm), a 
α-phosphoglucomutase, which converts glucose-6-phosphate (Glc-6-P) to glucose-1-
phosphate (Glc-1-P) (Gründling & Schneewind, 2007a; Lazarevic et al., 2005; Lu & 
Kleckner, 1994); GtaB (or GalU), which transfers UDP to glucose-1-phosphate, giving 
rise to UDP-Glc (Gründling & Schneewind, 2007a; Pooley et al., 1987); and YpfP (or 
UgtP), a processive glycosyltransferase which transfers two glucose moieties from 
UDP-Glc to DAG, generating Glc2-DAG and releasing UDP (Gründling & Schneewind, 
2007a; Jorasch et al., 1998; Kiriukhin et al., 2001) (Figure 4, steps 1 to 4). Lastly, Glc2-
DAG needs to be transported across the membrane to the outer leaflet of the membrane, 
where the PGP chain will be polymerised on this glycolipid. It is thought that in S. 
aureus LtaA a member of a major facilitator superfamily clan, and encoded in the same 
operon as ypfP (Gründling & Schneewind, 2007a) is involved in this flipping reaction 
(Figure 4, step 5).  
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All the enzymes involved in this process are not essential for cell viability since 
its mutants are still able to synthesise LTA but without a glycolipid anchor, resulting in 
LTA directly anchored to DAG (Gründling & Schneewind, 2007a; Lazarevic et al., 
2005). Cells from S. aureus ypfP mutants were shown to be misshaped and enlarged 
(Kiriukhin et al., 2001) but still viable. However, these mutants demonstrate varying 
phenotypes depending on the strain background. For instance, RN4220 ypfP mutants 
produce a slightly increased amount of PGP-LTA that is released into the supernatant 
(Kiriukhin et al., 2001) while SA113 ΔypfP contains significantly reduced amounts of 
LTA (Fedtke et al., 2007).  
As mentioned above, the PGP chain is polymerised on the outside of the cell and 
the LTA synthase (LtaS) is responsible for this reaction (Gründling & Schneewind, 
2007b) (Figure 4). LtaS is a polytopic membrane protein with five N-terminal 
transmembrane helices (5TM domains) and a C-terminal extracellular enzymatic 
domain (eLtaS) (Gründling & Schneewind, 2007b; Lu et al., 2009) (Figure 4). This 
enzyme is cleaved in the linker region between these two domains by the protease SpsB, 
which is thought to inactivate the enzyme that is only active when in its full-length form 
(Wörmann et al., 2011b).  
For LTA synthesis it has been proposed that the GroP subunits are derived from 
the head group of the membrane lipid phosphatidylglycerol (PG), which was first 
suggested by pulse-chase experiments (Koch et al., 1984). More recently an experiment 
using fluorescently labelled PG showed that LtaS is able to cleave GroP from PG in 
order to form DAG (Karatsa-Dodgson et al., 2010). The GroP subunits are then added 
to the distal end of the growing chain. Although in S. aureus LtaS is able to start and 
extend the PGP chain, it is important to note that in L. monocytogenes there is an LTA 
primase (LtaP), which is necessary to add the first GroP subunit to the glycolipid anchor 
(Webb et al., 2009). Similarly, B. subtilis expresses an enzyme with primase activity, 
YvgJ (Wörmann et al., 2011a). In fact, in B. subtilis there are four enzymes able to 
hydrolyse PG from membrane lipids: LtaS, YqgS, YvgJ and YfnI. The reason for the 
presence of multiple enzymes to synthesise LTA in B. subtilis comparing with the one-
enzyme system in S. aureus may be due to an interconnection between LTA synthesis, 
and environmental conditions and developmental processes, such as sporulation 
(Wörmann et al., 2011a).  
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In S. aureus, LtaS depletion results in inability to synthesise LTA and growth 
arrest associated with severe envelope and division defects (Gründling & Schneewind, 
2007b). In these conditions, cells present aberrant positioning of the septa, altered cell 
morphology and even lysed cells without cytoplasm or nucleic acids (Gründling & 
Schneewind, 2007b).  
 
1.2.3.3. The function and localisation of lipoteichoic acid 
 
In addition to WTA, LTA is also important to maintain the cell wall structure 
and has important functions in helping cells to adapt to different environmental factors. 
In S. aureus it has been shown that LTA is important to protect the cell in low 
osmolarity conditions, given the fact that an LtaS depleted strain is only able to survive 
at 37°C at high salt (7.5%) or sucrose (40%) (Oku et al., 2009). This may indicate that 
LTA act as an osmoprotectant under normal growth conditions.  
As described above, S. aureus mutants with depleted LtaS have misplaced 
division septa, which seems to indicate a role in cell division (Gründling & 
Schneewind, 2007b; Oku et al., 2009). This may be due to interactions with the 
membrane-bound division machinery (Xia et al., 2010). Although in S. aureus it is still 
not proved that LtaS localises at the division septa, in B. subtilis both LtaS and YqgS 
localise to the site of cell division and the absence of LtaS results in FtsZ delocalisation 
and subsequent misplacement of septa (Schirner et al., 2009). Also, the YpfP homolog 
in B. subtilis, UgtP, was shown to have a septal localisation, which is dependent on the 
presence of UDP-Glc, the substrate for this enzyme (Weart et al., 2007). Together, this 
data seem to indicate a link between LtaS and cell division. 
LTA, together with WTA, also has an important role in regulating autolytic 
activity in S. aureus, since in the absence of LtaS there is a decrease in autolytic activity 
(Oku et al., 2009). Furthermore, an LTA suppressor strain with mutations affecting the 
levels of the signalling molecule cyclic diadenosine monophosphate (c-di-AMP) was 
obtained (Corrigan et al., 2011) and in this strain there is a reduction in the levels of 
hydrolytic enzymes that were increased by the re-introduction of ltaS and consequent 
LTA production (Corrigan et al., 2011). Once again these observations support the role 
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of LTA in autolysis regulation and may be related to the fact that LTA is essential for 
ion binding, particularly Mg
2+
 ions (Heptinstall et al., 1970).  
Suggested function of LTA in the cell is closely related to its location and some 
suggested roles for this polymer are based on the assumption that this is a cell-surface 
exposed molecule. However, LTA is detected in the membrane and the detection of this 
polymer in whole cells of S. aureus is variable between strains (Aasjord & Grov, 1980). 
Furthermore, labelling experiments with positively charged gold nanoparticles 
suggested that the periplasmic space in B. subtilis is occupied by negatively charged 
components (Matias & Beveridge, 2008). These components could not be removed by 
protease treatment, indicating that these are not proteinaceous components, and could 
be detected by an LTA-specific monoclonal antibody (Matias & Beveridge, 2008). 
These data suggest that LTA might be the major component of the Gram-positive 
periplasm.  Additionally, LTA PGP chain synthesis by LtaS that uses PG as a substrate, 
and D-alanylation by Dlt proteins suggests that LTA needs to remain close to the 
membrane during and after its synthesis (Reichmann & Gründling, 2011). However, it 
is important not to forget the possibility that LTA is also involved in WTA D-
alanylation (Haas et al., 1984), which implies flexibility in the positioning of the LTA 
molecule.  
It has also been suggested that LTA has roles in adherence, biofilm formation 
and interactions with the molecules from the host immune system (Xia et al., 2010) but 
these are not compatible with the idea that LTA is not exposed at the cell surface. These 
roles might be related with the fact that LTA is also released from the bacterial cell and 
found in the supernatant (Fischer, 1988).  
 
1.2.3.4. D-Alanine incorporation into teichoic acids 
 
Both LTA and WTA are modified with D-alanine esters and this process, adding 
positive charges to the otherwise negatively charged polymers, is important to modulate 
envelope properties (Neuhaus & Baddiley, 2003).  
The enzymes involved in LTA D-alanylation are encoded in the dlt operon 
(Neuhaus et al., 1996; Perego et al., 1995). In S. aureus the dlt operon consists of five 
genes, dltX, A, B, C and D (Fischer, 1994). The dltX gene encodes DltX, which is a very 
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small protein with an expected size of 5.9 kDa and has been annotated to belong to the 
DUF3687 superfamily (Reichmann et al., 2013). In S. aureus and other gram-positive 
bacteria, this protein is encoded immediately upstream of dltA, but whether if functions 
in the D-alanylation process it is still unknown (Koprivnjak et al., 2006). The dltA gene 
encodes the D-alanine-D-alanyl carrier protein ligase (DltA) (Baddiley & Neuhaus, 
1960), which belongs to a family of enzymes that activate and transfer amino or fatty 
acids to a thiol group of the 4-phosphopantetheine prosthetic group of a carrier protein 
(Du et al., 2008; Osman et al., 2009). In the process of D-alanylation, its role is to ligate 
D-alanine to the 4-phosphopantetheine of the carrier protein DltC, leading to the release 
of adenosine monophosphate (AMP) (Heaton & Neuhaus, 1994; Neuhaus et al., 1996). 
DltB and DltD, encoded by dltB and dltD, respectively, have more questionable roles. 
DltB is predicted to be a polytopic membrane protein with 12 transmembrane domains 
and belongs to the membrane-bound O-acetyltransferases (MBOAT) family (Hofmann, 
2000). DltD is also a membrane protein that is likely to be anchored to the membrane 
via its N-terminus (Perego et al., 1995). The roles these enzymes play in the process of 
D-alanylation are divergent between two proposed models, one forward by Fisher and 
colleagues (1995) and the alternative proposed by Neuhaus & Baddiley (2003).  
In the first model (Figure 4) it was proposed that DltB acts as a facilitator to 
transfer D-alanines from the carrier protein, DltC, to undecaprenyl phosphate, C55-P, 
forming the lipid linked intermediate D-Ala-P-C55 (Perego et al., 1995). As a second 
role for DltB this protein would aid in traversing the intermediate to the outer leaflet of 
the membrane. In a final step, DltD would act on the outside of the cell and, with its 
positive charge, would be able to detect the negatively charged PGP from LTA and 
bring it in close proximity to the intermediate D-Ala-P-C55 (Perego et al., 1995). The 
second model, on the other hand, proposes that DltD acts in the cytoplasm by bringing 
in close proximity DltA and DltC, which would result in the efficient charging of DltC 
with D-alanines (Neuhaus & Baddiley, 2003). This hypothesis was made based on 
experiments using purified proteins from Lactobacillus rhamnosus, which showed a 
two-fold increase in the rate of ligation of D-alanines from DltA to DltC in the presence 
of DltD. Furthermore, this model proposes that DltC, once charged with D-alanines, is 
translocated across the membrane through a channel formed by DltB, before the D-
alanines are transferred to LTA on the outer leaflet of the membrane (Neuhaus & 
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Baddiley, 2003). Only recently it has been shown, using protein localisation and 
membrane topology analysis in S. aureus, that DltC remains within the cell, while DltD 
has an N-terminal embedded in the membrane and a C-terminus on the outer side of the 
membrane. These observations are in agreement with the model proposed by Fisher and 
colleagues (Reichmann et al., 2013).  
For WTA D-alanylation it is known that the dlt operon is also necessary for this 
process, since it is abolished in B. subtilis dlt mutants (Perego et al., 1995). However, it 
has been proposed that the Dlt proteins may not be directly involved and instead D-Ala-
LTA is the D-alanine donor for WTA (Haas et al., 1984). Pulse-chase experiments using 
[
14
C]-alanine showed that a decrease in radioactivity in LTA is coupled with an increase 
in radioactivity in WTA (Haas et al., 1984; Koch et al., 1985). However, there is still no 
direct evidence that D-Ala-LTA is the donor for WTA D-alanylation.  
 
1.2.3.5. Functions of D-alanine esters in teichoic acids 
 
Given the negative charges in TAs, their decoration with positively charged D-
alanine residues plays an important role in the function of these cell wall components. 
In the absence of D-alanylation the cell wall net charge at the surface becomes more 
negative and this has the effect of making the cell more susceptible to positively 
charged molecules such as cationic antimicrobial peptides (CAMPs), defensins and 
nisin (Fabretti et al., 2006; Kovács et al., 2006; Kramer et al., 2008; Peschel et al., 
1999), as well as to cells from the host immune system such as phagocytes and 
neutrophils, highlighting the importance of D-alanylation during infection (Collins et al., 
2002; Kristian et al., 2005; Poyart et al., 2003; Walter et al., 2007). In S. aureus, it has 
also been observed that dlt mutants have an impaired ability to form biofilms and a 
reduced adherence to epithelial cells (Gross et al., 2001; Weidenmaier et al., 2004b). 
The important role of TAs in scavenging ions, especially Mg
2+
 is related to D-
alanylation (Fischer et al., 1981; Koprivnjak et al., 2006). In fact, the dlt operon in S. 
aureus is downregulated in the presence of Mg
2+
 and also by an increase in NaCl 
concentration, as well as pH and temperature (Boyd et al., 2000; Koprivnjak et al., 2006; 
Novitsky et al., 1974). Although in S. aureus it is still not known how this process is 
regulated, it is known that in Streptococcus agalactiae and S. gordonii, the expression 
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of the dlt gene is under the control of the two-component systems DltRS and LiaRS, 
respectively (McCormick et al., 2011; Poyart et al., 2001). 
 
1.3. Objectives of this study 
 
Through the analysis of mutants defective in LTA synthesis, various functions 
have been attributed to this zwitterionic polymer. However, most of these roles are 
based on phenotypic analysis of mutants with altered LTA glycolipid anchor (Fedtke et 
al., 2007; Gründling & Schneewind, 2007a; Kiriukhin et al., 2001), since strains lacking 
the PGP chain are only viable under osmoprotective conditions or by the acquisition of 
suppressor mutations (Corrigan et al., 2011; Oku et al., 2009). Therefore little is known 
about the function of the PGP chain of LTA in S. aureus, including whether effects 
observed are direct or indirect, and so one key aim of this research was to provide 
further insights into roles of LTA. One such role is during D-alanine incorporation into 
WTA, whereby D-Ala-LTA has been proposed to act as the D-alanine donor (Haas et al., 
1984). However, direct experimental evidence is lacking, and so this study investigated 
this hypothesis.  
Under normal growth conditions, LTA is essential for S. aureus growth 
(Gründling & Schneewind, 2007b), though it is still not known if cells enter starvation 
and growth arrest under these circumstances or if the absence of this polymer causes 
actual cell death. In this study it is investigated whether the absence of LTA in S. aureus 
is bacteriostatic or bactericidal, which may indicate if LTA is a suitable target for new 
antimicrobials. Furthermore, due to its role in Mg
2+
 binding and predicted function in 
cation homeostasis, the influence of LTA depletion on membrane potential was 
investigated. It was also previously shown that in the absence of LTA S. aureus cells 
present misplaced septa, cell enlargement and eventually lyse (Gründling & 
Schneewind, 2007b). Additionally, in B. subtilis it was found that both UgtP, involved 
in glycolipid anchor synthesis, and LtaS localise at the site of cell division (Schirner et 
al., 2009). These seem to be good indications for a role of LTA in cell division. The 
localisation of LTA in S. aureus has been studied and is proposed to be an important 
component of the Gram-positive periplasm (Matias & Beveridge, 2008) being 
maintained in close proximity to the cell membrane without reaching the cell surface as 
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usually represented. At this location LTA is likely to have a physiological function 
during bacterial growth and cell division since the division machinery is mainly kept 
close to the membrane (Reichmann & Gründling, 2011). Therefore, in this study the 
localisation of LTA synthase, LtaS, was investigated using fusions to a green 
fluorescent protein (GFP). 
Nowadays, the process for LTA synthesis is mostly defined, as well as the 
enzymes involved in the process. However, the regulation of this process in accordance 
with the cell needs is mainly unknown. Another aim of this study is to determine if LTA 
production is regulated during growth or under stress conditions. Since LtaS is the 
enzyme responsible for the PGP chain polymerisation (Gründling & Schneewind, 
2007b) and is essential for LTA synthesis, regulation studies focused on the expression 
of the ltaS gene as well as LTA production levels. 
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2. Materials and Methods 
 
2.1. Bacterial strains, growth conditions and storage 
 
E. coli and S. aureus strains used in this study are shown in Table 1 with the 
respective references when applicable. The E. coli strain XL1 Blue was used for cloning 
and plasmid propagation. Strains were stored at -80°C by mixing 500 μl overnight 
culture with 500 μl freezer medium that consists of 10% bovine serum albumin and 
10% monosodium glutamate. E. coli strains were grown at 37°C with shaking at 180 
rpm in Luria Bertani (LB) broth or on LB agar. When necessary the medium was 
supplemented with the following antibiotics and inducers: Ampicillin (Amp), 100 μg/ml; 
Kanamycin (Kan), 30 μg/ml; 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-
gal), 40 µg/ml.   
S. aureus strains were grown at 37°C with shaking at 180 rpm in Tryptic Soy 
Broth (TSB) or on Tryptic Soy Agar (TSA). When necessary the medium was 
supplemented with the following antibiotics, inducers and indicators: Chloramphenicol 
(Cam), 5 to 10 μg/ml; Erythromycin (Erm), 10 μg/ml; Anhydrotetracycline (Atet), 100 
to 200 ng/ml; Isopropyl β-D-thiogalactosidase (IPTG), 1 mM; 5-bromo-4-chloro-3-
indolyl-β-D-galactopyranoside (X-gal), 100 µg/ml. 
All optical density (OD) was measured using the Biochrom Libra S11 
spectrophotometer. 
 
2.2. Recombinant DNA techniques 
2.2.1. Purification of plasmid DNA from E. coli 
 
Plasmid DNA was extracted from 5 ml E. coli overnight cultures using the 
Macherey-Nagel plasmid DNA purification kit, following the manufacturer’s 
instructions. The plasmid DNA was eluted in 40 μl ddH2O. When higher amounts were 
needed plasmid DNA was isolated from 200 ml overnight cultures using the QIAGEN 
 20 
plasmid midi kit, following the manufacturer’s instructions. The DNA was rehydrated 
in 150 μl ddH2O. Plasmid DNA was stored at -20°C. 
 
2.2.2. Isolation of chromosomal DNA from S. aureus 
 
In order to isolate S. aureus chromosomal DNA, a 4 ml overnight culture was 
centrifuged for 20 min at 1,303 xg. The pellet was suspended in 50 μl TSM buffer (50 
mM Tris HCl pH 7.5, 0.5 M sucrose, 10 mM MgCl2 filter sterilised) and the cell wall 
was digested for 30 min at 37°C using lysostaphin (AMBI Products) at a final 
concentration of 100 μg/ml. The subsequent steps of the chromosomal DNA isolation 
were performed using the Wizard Genomic DNA Purification kit (Promega, Madison 
USA) and following the manufacturer’s protocol. The DNA was rehydrated in 40 μl 
ddH2O for 1 h at room temperature and stored at -20°C.  
 
2.2.3. Polymerase Chain Reaction (PCR) 
 
All the primers used in this study were ordered from Sigma Aldrich and can be 
found in Table 2. In general all the reactions were performed in a total volume of 50 μl, 
adding 2 μl of 40 mM dNTPs, 1 μl of each primer at a concentration of 10 mM, 50 to 
100 ng of template DNA, polymerase enzymes with their respective buffers, where for 
cloning 1 μl Herculase II (Agilent) was used with 10 μl 5X Herculase buffer and for all 
other PCR reactions, 0.5 μl Taq (New England Biolabs) with 5 μl 10X Taq buffer, and 
ddH2O to obtain the final volume. In order to fuse different fragments Splicing by 
Overlap Extension PCR (SOE PCR) was used. In these reactions 2 μl from each PCR 
product was used as the DNA template.  
The PCR program consisted of an initial denaturation step at 94°C for 2 min, 
followed by 5 cycles of denaturation at 94°C for 30 seconds, annealing at 45°C for 30 
seconds and extension at 72°C for a time dependent on the length of the product (1 min 
per 1 kb). Subsequently, these conditions were repeated for another 25 cycles, but this 
time with an annealing temperature of 53°C. A final extension at 72°C for 7 min was 
performed and the reaction was held at 10°C, ready for use or to be store at -20°C. All 
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PCR products were purified using the QIAquick Gel Extraction kit or the QIAquick 
PCR purification kit (QIAGEN) following the manufacturer’s instructions and eluted in 
50 μl 5mM Tris HCl pH 8. 
 
2.2.4. Restriction digests of plasmids and PCR fragments 
 
Plasmid DNA was digested with restriction enzymes from New England Biolabs 
for cloning or to check inserts sizes in plasmids after cloning. For cloning, reactions 
were prepared using 10 μg DNA, 2 μl enzyme, 10 μl 10X enzyme buffer, 1 μl 100X 
BSA (when necessary) and ddH2O to obtain a final volume of 100 μl. The reaction was 
incubated for 4 h at 37°C (except for SalI and BglII digests where the reactions were 
incubated for 16 h). In order to check inserts in plasmids, reactions were prepared using 
0.1-1 μg DNA, 0.25 μl enzyme, 2 μl 10X enzyme buffer, 0.2 μl 100X BSA (when 
necessary) and ddH2O to obtain a final volume of 20 μl. The reactions were incubated 
for 2 h at 37°C. 
Ligation reactions were prepared in a final volume of 25 μl using a molar ratio 
of 1:3 vector to insert, 1 μl T4 DNA ligase (New England Biolabs), 2.5 μl 10X T4 DNA 
ligase buffer and ddH2O to obtain the right volume. The reaction was incubated at 17°C 
for 16 h and heat-inactivated for 20 min at 65°C. 
 
2.2.5. Sequencing of clones 
 
After cloning all plasmid inserts were sequenced at the MRC CSC Genomics 
Core Laboratory at the Hammersmith Campus (Imperial College London) using 
fluorescent automated sequencing. The inserts of interest were PCR amplified using 25 
μl Taq polymerase and purified using the QIAquick Gel Extraction kit or the QIAquick 
PCR purification kit (QIAGEN). Reactions for sequencing were prepared adding 10 ng 
per 100 bp of PCR product, 2 μl primer (10 mM) and ddH2O to give a total volume of 
10 μl. The sequencing results were analysed by aligning the result with a predicted 
sequence using the program SeqMan from Lasergene 8, DNASTAR.  
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2.2.6. Preparation and transformation of chemically competent E.coli 
cells 
 
In order to prepare chemically competent E. coli cells, 20 ml of an overnight 
culture was back diluted 1:100 in 1 L PSI broth (5 g/L bacto yeast extract, 20 g/L bacto 
tryptone, pH 7.6, 20 mM MgSO4). The culture was incubated at 37°C with shaking at 
180 rpm until an OD600nm of 0.5-0.7. Once grown, the culture was incubated on ice for 
15 min and centrifuged at 3,847 xg for 10 min. The pellet was suspended in 200 ml 
sterile TfbI buffer (15% glycerol, 30 mM potassium acetate, 100 mM rubidium chloride, 
10 mM calcium chloride, 50 mM manganese chloride) and incubated on ice for 15 min. 
The suspension was centrifuged at 3,847 xg for 10 min. The pellet was suspended in 20 
ml sterile TbfII buffer (15% glycerol, 10 mM MOPS, 75 mM calcium chloride, 10 mM 
rubidium chloride) and incubated on ice for 15 min. The cell suspension obtained was 
separated into 500 μl aliquots, snap frozen in a dry ice/ethanol bath and stored at -80°C.  
In order to transform chemically competent E. coli cells, 12.5 μl of heat-
inactivated ligation mixture was added to 100 μl competent cells and incubated on ice 
for 30 min. The mixture was submitted to a heat shock by incubating at 42°C for 45 
seconds and then incubated on ice for 5 min. Nine hundred μl SOC medium (5 g/L 
bacto yeast extract, 20 g/L bacto tryptone, 3.6 g/L glucose, 2.5 mM KCl, pH 7.0) was 
added to the cells, which were recovered by incubation at 37°C for 1 h. One hundred μl 
from the suspension was spread on LB agar with the appropriate antibiotics. The 
remaining cell suspension was pelleted at 17,000 xg for 5 min, 750 μl of the supernatant 
was removed, and the pellet was suspended in the remaining liquid and plated on LB 
agar plates with the appropriate antibiotics. Plates were incubated at 37°C overnight to 
obtain single colonies.  
 
2.2.7. Preparation and electroporation of electrocompetent S. aureus 
cells 
 
In order to prepare electrocompetent S. aureus cells, an overnight culture was 
grown shaking at 37°C in TSB with the appropriate antibiotics (when necessary). The 
following day, the culture was back diluted 1:100 in 150 ml TSB and incubated at 37°C 
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shaking at 180 rpm until an OD600nm of around 2.1. The cells were then centrifuged at 
6,000 xg for 10 min at 4°C. The pellet was washed twice with 150 ml sterile 0.5 M 
sucrose and once with 75 ml sterile 0.5 M sucrose. The final pellet was suspended in 1.5 
ml sterile 0.5 M sucrose. The cell suspension obtained was separated in 230 μl aliquots 
that were snap frozen in a dry ice/ethanol bath before storage at -80°C. 
Aliquots of 110 μl of cells were pipetted into 1 mm electroporation cuvettes 
(Biorad) and 20 μl of plasmid DNA in a concentration range of 300-600 ng/μl 
previously dialysed against ddH2O was added. For electroporation, a Biorad Gene 
Pulser with 100 Ω, 2.5 kV and 25 µF settings was used. After electroporation, cells 
were recovered with 900 μl BHI 0.5 M sucrose medium, incubated for 1 h at 37°C and 
100 μl cells were spread on TSA plates with the appropriate antibiotics. The remaining 
cell suspension was pelleted at 10,000 xg for 3 min and 750 μl from the supernatant was 
removed. The pellet was suspended in the remaining liquid and plated on TSA with the 
appropriate antibiotics. Plates were incubated at 37°C overnight and single colonies 
were re-streaked twice on TSA plates. Single colonies were used to inoculate TSB 
media with the appropriate antibiotics to grow overnight and freeze the cultures the next 
day.  
 
2.2.8. Phage transduction in S. aureus cells 
 
2.2.8.1. Preparation of phage lysates 
 
For the preparation of phage lysates, the donor strains were grown in 4.5 ml 
LB/TSB in a ratio of 2:1 supplemented with 5 mM CaCl2 and incubated shaking at 
37°C overnight. The next day, the culture was diluted 1:50 into new media with the 
same composition and grown for 3 h shaking at 37°C. A lysate of the transducing phage 
85 was diluted in 10-fold dilutions from 10
-1
 to 10
-6
 in TMG buffer (10 mM Tris-HCl 
pH 7.4, 10 mM MgSO4, 0.1% gelatin) and 100 μl of each dilution was incubated with 
500 μl of culture from the donor strain at room temperature for 30 min to enable phage 
adsorption. To each mixture, 5 ml top agar cooled to 42°C (0.8% NaCl, 0.8% Bacto-
agar) was added. Thin TSA plates pre-warmed to 37°C supplemented with the 
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appropriate antibiotics were overlaid with 5.5 ml cells in top agar and incubated with 
the lid side up at 37°C overnight. The next day, the plate with a semi-confluent layer of 
plaques was overlaid with 4 ml TMG buffer and incubated for 20 min at room 
temperature. The liquid was pipetted into a 15 ml tube and centrifuged for 20 min at 
3,220 xg to pellet cellular debris and the supernatant was sterile filtered using a 0.22 
mm filter. The phage lysates were stored at 4°C.  
 
2.2.8.2. Phage transduction of S. aureus 
 
The recipient strains were grown overnight in 24 ml LB/TSB in a ratio 2:1 
supplemented with 5 mM CaCl2. The following day, cells were harvested by 
centrifugation for 20 min at 3,220 xg and suspended in 4.5 ml LB/TSB in a ratio 2:1. To 
a 250 μl aliquot of cells, 200 μl lysate was added and incubated at 37°C shaking for 20 
min. Cells were placed on ice and 24 μl 1 M sodium citrate was added to inhibit 
infection. Cells were pelleted at 10,000 xg for 3 min and washed twice with 1 ml 40 
mM sodium citrate. The final pellet was suspended in 300 μl 40 mM sodium citrate, and 
100 μl and 200 μl were spread on TSA supplemented with 40 mM sodium citrate and 
the appropriate antibiotics. The TSA plates were incubated for 48 h at 37°C and single 
colonies were streaked twice on new TSA plates supplemented 40 mM sodium citrate 
and the appropriate antibiotics. 
 
2.3. Strain and plasmid construction 
 
2.3.1. ltaS promoter-lacZ fusions constructs 
 
For LacZ fusions to the ltaS promoter region, different sized fragments were 
cloned into the vector pCL55iTET-lacZ upstream of the lacZ gene. The full-length 5’ 
UTR region (700 bp) and truncated versions (473 bp, 400 bp, 300 bp, 200bp and 100 
bp) were amplified from S. aureus RN4220 chromosomal DNA using primer pairs 
1058/1052, 1047/1052, 1048/1052, 1049/1052, 1050/1052 and 1051/1052, respectively. 
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All the PCR products and pCL55iTET-lacZ were digested with KpnI/SalI and ligated. 
The resulting plasmids (pCL55p700ltaS-lacZ, pCL55p473ltaS-lacZ, pCL55p400ltaS-
lacZ, pCL55p300ltaS-lacZ, pCL55p200ltaS-lacZ and pCL55p100ltaS-lacZ) were first 
obtained in E. coli XL1 Blue yielding strains ANG2028, ANG2029, ANG2030, 
ANG2031, ANG2032 and ANG2033, respectively. The plasmids were then introduced 
into S. aureus RN4220 yielding strains ANG2866, ANG2867, ANG2868, ANG2869, 
ANG2870 and ANG2871, respectively. Similarly, the plasmids integrated into the 
chromosome were transduced into S. aureus LAC* generating strains ANG2964, 
ANG2965, ANG2966, ANG2967, ANG2968 and ANG2969, and into S. aureus 
Newman resulting in strains ANG2970, ANG2971, ANG2972, ANG2973, ANG2974 
and ANG2975, respectively.  
In order to delete the bases from 400 to 30 from the full-length UTR producing 
pCL55pΔ400-30ltaS-lacZ, two fragments were amplified from pCL55p700ltaS-lacZ 
using primer pairs 1058/1232 and 1233/817 and the PCR fragments were fused by SOE 
PCR using primer pair 1058/817. For the deletion of the P2 region, the bases 294 to 30 
were deleted, constructing pCL55pΔ294-30ltaS-lacZ by amplifying two fragments from 
pCL55p700ltaS-lacZ with primer pairs 1058/1234 and 1235/817, and these PCR 
fragments were fused by SOE PCR using primer pair 1058/817. In order to mutate the 
transcriptional start site located 294 bp upstream of the start codon and obtain 
pCL55pΔ294ltaS-lacZ, two fragments were amplified from pCL55p700ltaS-lacZ using 
primer pairs 1058/1236 and 1237/817, and these PCR fragments were fused by SOE 
PCR using primer pair 1058/817. All PCR products and pCL55iTET-lacZ were digested 
with KpnI/SalI before ligation. The plasmids pCL55pΔ400-30ltaS-lacZ and 
pCL55pΔ294ltaS-lacZ were first obtained in E. coli XL1 Blue yielding strains 
ANG2204 and ANG2206, and afterwards introduced into S. aureus RN4220Δspa 
yielding strains ANG2961 and ANG2963. The plasmid pCL55pΔ294-30ltaS-lacZ was 
electroporated directly into S. aureus RN4220Δspa generating strain ANG2962. The 
three plasmids were also introduced into S. aureus LAC* yielding strains ANG2976, 
ANG2977 and ANG2978 and into S. aureus Newman yielding strains ANG2979, 
ANG2980 and ANG2981. 
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2.3.2. Construction of gfpP7-ltaSS218P fusions 
 
For the LtaS localisation studies, a fast folding version of GFP (GFPP7) was 
fused to the N-terminal end of the non-cleavable LtaSS218P variant, with and without a 
3x EAAAK amino acid linker region. These fusions were expressed either form the ltaS 
native promoter or the Atet inducible iTET promoter. 
For construction of pCL55pltaS-gfpP7-ltaSS218P, the promoter sequence of ltaS 
was amplified from Newman chromosomal DNA using primer pair 1334/1697 and gfpP7 
was amplified from pTrc99A-gfpP7 using primer pair 1698/1699. These PCR products 
were fused by SOE PCR using primer pair 1334/317, resulting in the pltaS-gfpP7 
fragment. The gene ltaSS218P was amplified from pOK-ltaSS218P using primer pair 
1700/317 and fused to pltaS-gfpP7 using primer pair 1334/317, giving rise to pltaS-
gfpP7-ltaSS218P. The final PCR product and pCL55 were digested with EcoRI/KpnI and 
ligated. The plasmid pCL55pltaS-gfpP7-ltaSS218P was initially obtained in E. coli XL1 
Blue yielding the strain ANG2990 and subsequently introduced into S. aureus strains 
RN4220Δspa, LAC* and LAC*-iltaS yielding strains ANG3018, ANG3022 and 
ANG3026 respectively.  
For construction of a pltaS-gfpP7-linker-ltaSS218P fusion, the promoter sequence 
of ltaS was amplified from Newman chromosomal DNA using primer pair 1334/1697 
and gfpP7 was amplified from pTrc99A-gfpP7 using primer pair 1698/1699. These PCR 
products were fused by SOE PCR using primer pair 1334/1701, giving rise to pltaS-
gfpP7. The gene ltaSS218P was amplified from pOK-ltaSS218P using primer pair 1700/317 
and both pltaS-gfpP7 and  ltaSS218P were digested with SacII and ligated. The ligation 
product was amplified using primer pair 1334/317 to yield the fusion pltaS-gfpP7-linker-
ltaSS218P. The final PCR product and pCL55 were digested with EcoRI/KpnI and ligated. 
The plasmid pCL55pltaS-gfpP7-linker-ltaSS218P was initially obtained in E. coli XL1 
Blue yielding the strain ANG2991 and subsequently introduced into S. aureus strains 
RN4220Δspa, LAC* and LAC*-iltaS yielding strains ANG3019, ANG3023 and 
ANG3027 respectively. 
For construction of pCL55iTET-gfpP7-ltaSS218P fusion, gfpP7 was amplified from 
pTrc99A-gfpP7 using primer pair 1702/1699 and ltaSS218P was amplified from pOK- 
ltaSS218P using primer pair 1700/319. The gfpP7-ltaSS218P fragment was fused by SOE 
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PCR using primer pair 1702/319. The final PCR product and the plasmid pCL55iTET 
were digested with AvrII/BglII and ligated. The plasmid pCL55iTET-gfpP7-ltaSS218P was 
initially obtained in E. coli XL1 Blue yielding strain ANG2992 and subsequently 
introduced into S. aureus strains RN4220Δspa, LAC* and LAC*-iltaS yielding strains 
ANG3020, ANG3024 and ANG3028 respectively. 
For construction of pCL55iTET-gfpP7-linker-ltaSS218P fusion, gfpP7 was 
amplified from pTrc99A-gfpP7 using primer pair 1702/1701 and ltaSS218P was amplified 
from pOK- ltaSS218P using primer pair 1337/319. Both PCR products were digested with 
SacII and ligated. The ligation product was amplified using primers 1702/319 to yield 
fusion iTET-gfpP7-linker-ltaSS218P. The final PCR product and pCL55iTET were 
digested with AvrII/BglII and ligated. The plasmid pCL55iTET-gfpP7-linker-ltaSS218P 
was initially obtained in E. coli XL1 Blue yielding strain ANG2993 and subsequently 
introduced into S. aureus strains RN4220Δspa, LAC* and LAC*-iltaS yielding strains 
ANG3020, ANG3024 and ANG3028 respectively. 
 
2.4. S. aureus growth curves 
 
RN4220 (ANG113), RN4220∆spa (ANG314), LAC* (ANG1575), RN4220-
iltaS (ANG499) and LAC*-iltaS (ANG 2505) S. aureus strains and the remaining 
strains of interest for fluorescence microscopy were grown overnight at 37°C with 
shaking in TSB or LB supplemented with the appropriate antibiotics and 1 mM IPTG 
for the inducible strains. The next day, 1 ml culture was washed three times in TSB or 
LB and diluted 1:100 into 5 ml TSB or LB medium with and without IPTG, 
supplemented with the appropriate antibiotics. The cultures were grown at 37°C with 
shaking and bacterial growth was monitored by determining OD600nm every 2 h until the 
8 h timepoint. At the 4 h time point, cultures were diluted 1:100 into fresh TSB or LB 
medium to maintain bacteria in the exponential growth phase.  
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2.5. Live/Dead bacterial viability assay 
 
The same S. aureus strains as used for growth curves (see section 2.4. S. aureus 
growth curves) were grown overnight at 37°C with shaking in TSB supplemented with 
the appropriate antibiotics and 1 mM IPTG for the inducible strains. The next day 1 mL 
culture was washed three times in TSB and diluted 1:400 into 25 ml TSB medium with 
and without IPTG, supplemented with the appropriate antibiotics. Cultures were grown 
at 37°C with shaking and bacterial growth was monitored by determining OD600nm 
every 2 h until the 6 h timepoint. From the overnight culture and at each time point, a 1 
ml sample was centrifuged at 10,000 xg for 3 min and suspended in a volume of 0.85% 
NaCl normalised for OD600nm readings (where a culture with OD600nm of 0.5 was 
suspended in 100 μl 0.85% NaCl).  
In order to distinguish between living and dead cells, the Live/Dead Baclight 
Bacterial Viability Kit (Invitrogen) was used. Following the manufacturer’s instructions, 
equal volumes of component A (SYTO 9 dye) and component B (propidium iodide) 
were mixed and diluted 1:10 in DMSO (dimethyl sulfoxide). Of this mixture, 3 μl was 
added to 100 μl bacterial culture (suspended in 0.85% NaCl). Four μl was spotted on the 
slide and covered with a coverslip, before observation using a Nikon Eclipse E600 
microscope equipped with a Nikon Digital DXM1200 camera and Digital Sight ACT-1 
software. Cells were counted using the Image J software.  
 
2.6. Membrane potential assay 
 
Changes in membrane potential were determined as previously described with 
slight modifications (Li et al., 2009). The same strains, which were analysed in the 
Live/Dead assay experiment (see section 2.5. Live/dead bacterial viability assay) were 
used and the cultures were prepared following the same procedure, with the exception 
that Mueller-Hinton broth (Fluka) supplemented with 25 mg/L Ca
2+
 and 12.5 mg/L 
Mg
2+ 
(CA-MHB) was used for growth. At each time point, a 1 ml sample was 
centrifuged at 10,000 xg for 3 min and washed once with 1 ml buffer A (5mM HEPES 
pH 7.2, 5mM glucose). The cell suspension was centrifuged again at 10,000 xg for 3 
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min, suspended in 1 ml buffer B (5mM HEPES pH 7.2, 5mM glucose, 100mM KCl) 
and diluted in the same buffer for a final OD600nm of 0.05. Two hundred μl of this 
suspension were added to a black 96-well polystyrene fluorescence MaxiSorp plate 
(Thermo Scientific Nunc) plate. The membrane potential-sensitive fluorescent dye 3,3’-
dipropylthiadicarbocyanine iodide (DiSC3(5), Invitrogen) was added at a final 
concentration of 2 μM and the samples were incubated for 15 min to enable dye uptake 
and fluorescence quenching. Buffer B only and buffer B with dye was used as 
background and positive controls respectively. To one sample with wild-type bacteria, 
nisin, a pore forming peptide, was added at a final concentration of 10 μg/ml in order to 
guarantee fluorescence can be detected when there is no dye uptake. The fluorescence 
was measured at an excitation wavelength of 622 nm and emission wavelength of 670 
nm. 
 
2.7. β-Galactosidase activity assay in S. aureus 
 
 S. aureus strains of interest were grown overnight in 4 ml TSB supplemented 
with the appropriate antibiotics at 37°C with shaking. The following day cultures were 
diluted 1:100 into 5 ml fresh TSB medium and grown at 37°C with shaking and as 
negative control, S. aureus RN4220 pCL55iTET was grown in the presence of 200 
ng/ml Atet. 
Cultures were grown without inducer for 4 h and with inducer for 5 h. The 
OD600nm was recorded, 1 ml from each culture centrifuged at 17,000 xg for 10 min and 
pellets were subsequently suspended in 1 ml ABT buffer (60 mM K2HPO4, 40 mM 
KHPO4, 100 mM NaCl, pH 7.0, 1% Triton X-100) containing 20 μg/ml lysostaphin and 
incubated at 37°C for 30 min to allow cell lysis. Cell debris were pelleted by 
centrifugation at 17,000 xg for 10 min and 100 μl supernatant was incubated for 1 h at 
room temperature in the dark with 20 μl 0.4 mg/ml 4-methyl umbelliferyl β-D-
galactopyranoside (MUG) in a black 96-well polystyrene fluorescence MaxiSorp plate 
(Thermo Scientific Nunc). As a background control it was used 100 μl ABT buffer. 
Following the incubation, 20 μl was mixed with 180μl ABT buffer and the fluorescence 
was measured at an excitation wavelength of 336 nm and emission wavelength of 445 
nm. In order to obtain a standard curve, 2-fold serial dilutions of 4-methylumbilliferone 
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(MU) in ABT buffer at known concentrations were made and subsequently these values 
were used to determine the concentration (in μM) of product in each sample. 
 
2.8. Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis 
(SDS-PAGE) and western immunoblot 
 
 In order to separate proteins and LTA prior to western immunoblot analysis, 
sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) was 
performed using 10 % or 15 % polyacrylamide gels produced as previously described 
(Sambrook et al., 1989). In order to estimate protein size, 5 µl of protein ladder 
(BenchMarkTM Prestained, Invitrogen or PageRuler Plus Prestained Protein Ladder, 
Thermo Scientific) was loaded beside 10 µl of the different samples, and separated by 
electrophoresis at 200 V (with the exception of LtaS samples that were separated at   
100 V) using a Hoefer Mini Protein Electrophoresis system in 1X SDS buffer (14.4 g/L 
glycine, 3 g/L Tris-base, 1 g/L SDS). 
All the western immunoblot procedures were performed using polyvinylidene 
difluoride (PVDF) membranes activated in methanol. Proteins and LTA were 
transferred for 1 h with a constant current of 1000 mA using a Hoefer electrophoretic 
transfer cell system filled with transfer buffer [3 g/L Tris-base, 14.5 g/L glycine, 20 % 
(v/v) methanol]. After the transference, the membranes were blocked for 1 h at room 
temperature in 5% (w/v) milk in 1X TBST (50 mM Tris-base, 150 mM NaCl, 0.1% 
tween, pH 7.4). When necessary, 10 μg/ml human IgG was added to all incubation steps, 
in order to inhibit the binding of S. aureus protein A. Following the blocking step, 
membranes were incubated with the primary antibody overnight at 4°C in 5% (w/v) 
milk in TBST. The following day the membranes were washed three times with 20 ml 
TBST for 10 min, prior to incubation with the secondary antibody, when necessary, 
which was performed for 3 h in 5% (w/v) milk in TBST. The membranes were washed 
as previsously prior to detection. Detection was performed by incubating the 
membranes for 2 min with ECL (100 mM Tris-HCl pH 8.5, 2.5 mM luminol, 2.5 mM 
P-coumaric acid) containing 0.009 % (v/v) hydrogen peroxide, with the exception of the 
LtaS protein prepared from strains with inducible ltaS, where the signal was detected 
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using the Amersham ECL Prime Western Blotting Detection Kit (GE Healthcare), 
following the manufacturer’s instructions. The chemiluminescent signal was detected in 
an ECL Hyperfilm (GE Healthcare) and the film was developed using AGFA-
Healthcare N. V. automated developer. Exposure time was variable depending on signal 
strength.   
 
2.8.1. Preparation of samples and detection of LTA by western 
immunoblot 
 
In order to obtain LTA samples for immunoblot analysis, the same S. aureus 
strains as used for growth curves (see section 2.4. S. aureus growth curves) were grown 
overnight at 37°C with shaking in TSB supplemented with the appropriate antibiotics 
and 1 mM IPTG for the inducible strains. The following day 1 ml culture was washed 
three times in TSB and diluted 1:100 into 5 ml TSB medium with and without IPTG for 
the inducible strains and supplemented with the appropriate antibiotics. Cultures were 
grown for 4 h at 37°C with shaking and bacterial growth was monitored by determining 
OD600nm every 2 h. Cells were lysed by adding 1 ml culture to 0.5 ml of 0.1 mm glass 
beads and vortexing upside down for 45 min at 4°C. In order to settle the beads, the 
samples were centrifuged for 1 min at 200 xg and the supernatant containing lysed 
bacteria was transferred into a fresh eppenford tube. Bacterial debris was collected by 
centrifuging for 15 min at 17,000 xg. The pellet containing LTA was suspended in 2 % 
SDS-containing sample buffer normalised for OD600nm readings (where a culture with 
OD600nm of 3 was suspended in 90 μl buffer). Samples were boiled for 20 min and 
centrifuged for 5 min at 17,000 xg, before loading 10 μl onto a 15% polyacrylamide gel.  
 Following SDS-PAGE and transfer to a PVDF membrane, LTA was detected 
using a 1:5000 dilution of mouse monoclonal LTA antibody (HyCult Biotechnology) 
and a 1:10000 dilution of horseradish peroxide HRP-conjugated anti-mouse secondary 
antibody as described in section 2.8.  
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2.8.2. Preparation of samples and detection of LtaS by western 
immunoblot 
 
In order to obtain samples for LtaS immunoblot analysis, cells were grown 
following the same procedure as for LTA samples (see section 2.8.1. Preparation of 
samples and detection of LTA by western immunoblot). To prepare the cell fraction 
(containing the cell wall, cell membrane and cytoplasm), 1 ml cell culture was pelleted 
by centrifugation at 17,000 xg for 5 min. The pellet was suspended in cell lysis buffer 
(100 mM Tris-HCl pH 7.5, 10mM MgCl2, 200 μg/ml lysostaphin, 100 μg/ml DNase) 
normalised for OD600nm reading (where a culture with OD600nm of 3 was suspended in 45 
μl buffer). After incubation for 30 min at 37°C, 2 % SDS-containing sample buffer was 
added (same volume as cell lysis buffer). Samples were boiled for 15 min, centrifuged 
at 17,000 xg for 5 min and 10 μl aliquots were separated on 10 % polyacrylamide gels 
for western blot analysis.  
For LtaS detection, a 1:20000 dilution of a rabbit polyclonal LtaS antibody was 
used prior to incubation with an HRP-conjugated anti-rabbit IgG antibody at a 1:10000 
dilution as described in section 2.8.  
 
2.9. Preparation of cell wall and WTA purification for analysis by 
NMR 
 
Purification of peptidoglycan-WTA complexes purification was performed as 
previously described (Bernal et al., 2009; Kopp et al., 1996; Stranden et al., 1997) with 
slight modifications. Overnight cultures of S. aureus were diluted into 1 L TSB to 
obtain an initial OD600nm of approximately 0.06 (5 L batches were used for each strain) 
and grown at 37°C with shaking until an OD600nm of approximately 3. Bacteria were 
collected by centrifugation at 6,000 xg for 10 min and washed once with 1 M NaCl. 
Cells were disrupted with 0.1 mm glass beads and the broken cells were collected by 
centrifugation for 40 min at 13,300 xg. The cell wall material was washed once with 1 
M NaCl, three times with 0.5 % (w/v) sodium dodecyl sulphate (SDS) and three times 
with water. The material in solution was incubated with gentle stirring for 30 min at 
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60°C, removing non-covalently bound components. The cell wall material was 
recovered by centrifugation at 34,572 xg for 20 min, washed with water once and 
recovered again by centrifugation. The pellet was suspended in 0.15 mM Tris-HCl pH 
7.0 with trypsin (0.2 mg/ml) and incubated at 37°C for 18 h to remove cell wall 
proteins. The material was recovered by centrifugation and washed with 1 M Tris-HCl 
pH 7.0, 1 M Tris-HCl pH 7.0 containing 1 M NaCl, 1 M Tris-HCl pH 7.0 and three 
times with water. In order to hydrolyse WTA from peptidoglycan, the cell wall material 
was incubated in 10 % (w/v) TCA at 4°C for 18 h. The peptidoglycan was removed by 
centrifugation at 9,690 xg for 45 min. WTA was precipitated with 0.1 volumes 3 M 
sodium acetate pH 5.2 and 3 volumes 95 % ice cold ethanol and held overnight at -
80°C. The following day, the WTA was precipitated by centrifugation at 9,690 xg for 
30min and was washed five times with 95 % ethanol. Following the final wash, the 
ethanol was evaporated and the WTA was suspended in 500 μl water and lyophilised 
overnight.  
For NMR analysis, 6 mg WTA was suspended twice in 99.96 % D2O and 
lyophilised, prior to suspension in 99.99 % D2O. Spectra were acquired on a 600 MHz 
Bruker AVANCE III spectrometer equipped with TCI cryoprobe, and processed using 
Bruker TopSpin 3.1 software. 
 
2.10. Fluorescence microscopy 
 
 Strains were prepared for fluorescence microscopy by growing the different S. 
aureus strains in 5 ml TSB supplemented with the appropriate antibiotics at 37°C with 
shaking overnight. The next day, cultures were diluted 1:1000 into 5 ml TSB without 
antibiotics and grown to an OD600nm of 0.8 (mid-exponential phase). A 1 ml aliquot was 
pelleted by centrifugation at 17,000 xg for 1 min and suspended in 25 μl PBS 
(phosphate buffered saline). Two μl was spotted on 1.2% PBS agarose slides and 
covered with a coverslip before observation by Dr. Nathalie Reichmann in Dr. Mariana 
Pinho’s laboratory (Instituto de Tecnologia Química e Biológica, Portugal) on a Zeiss 
Axio Observer microscope equipped with a Phtometrics CoolSNAP HQ2 camera 
(Roper Scientific) and Metamorph software. 
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Table 1 - Strains used in this study 
 
Strain Relevant features Reference 
 
XL1 Blue 
Escherichia coli strains 
Cloning strain. TetR – ANG 127 
 
Stratagene 
ANG 243 pCL55 in XL1 Blue; S. aureus single site integration vector. 
AmpR 
(Lee et al., 1991) 
ANG 284 pCL55iTET in XL1 Blue; pCL55 containing Atet inducible 
promoter. AmpR 
(Gründling & 
Schneewind, 2007b) 
ANG 286 pCL55iTET-lacZ in XL1 Blue; AmpR Lab strain collection 
ANG 1242 pOK-ltaSS218P in XL1 Blue. KanR (Wörmann et al., 
2011b) 
ANG 2028 pCL55p700ltaS-lacZ in XL1 Blue; AmpR Lab strain collection 
ANG 2029 pCL55p473ltaS-lacZ in XL1 Blue; AmpR Lab strain collection 
ANG 2030 pCL55p400ltaS-lacZ in XL1 Blue; AmpR Lab strain collection 
ANG 2031 pCL55p300ltaS-lacZ in XL1 Blue; AmpR Lab strain collection 
ANG 2032 pCL55p200ltaS-lacZ in XL1 Blue; AmpR Lab strain collection 
ANG 2033 pCL55p100ltaS-lacZ in XL1 Blue; AmpR Lab strain collection 
ANG 2204 pCL55pΔ400-30ltaS-lacZ in XL1 Blue; AmpR Lab strain collection 
ANG 2206 pCL55pΔ294ltaS-lacZ in XL1 Blue; AmpR Lab strain collection 
ANG 2956 pTrc99A-gfpP7 in (Fisher & DeLisa, 
2008) 
ANG 2990 pCL55pltaS-gfpP7-ltaSS218P in XL1 Blue; AmpR This study 
ANG 2991 pCL55pltaS-gfpP7-linker-ltaSS218P in XL1 Blue; AmpR This study 
ANG 2992 pCL55iTET-gfpP7-ltaSS218P in XL1 Blue; AmpR This study 
ANG 2993 pCL55iTET-gfpP7-linker-ltaSS218P in XL1 Blue; AmpR This study 
 
 
RN4220 
 
Staphylococcus aureus strains 
Transformable laboratory strain – ANG 113 
 
 
(Kreiswirth et al., 
1983) 
SEJ1 RN4220Δspa – ANG314 (Gründling & 
Schneewind, 2007a) 
AH1263 LAC* - ANG1575 (Boles et al., 2010) 
ANG 467 Newman ΔΦ4 (Corrigan et al., 2013) 
ANG499 RN4220-iltaS; strain with IPTG-inducible ltaS expression; ErmR, 
IPTG 
(Gründling & 
Schneewind, 2007b) 
ANG1786 4S5; derivative of RN4220Δspa ΔltaS with suppressor mutations, 
lacking LTA 
(Corrigan et al., 2011) 
ANG2505 LAC*-iltaS; strain with IPTG-inducible ltaS expression; ErmR, 
IPTG 
Lab strain collection 
ANG2392 pCL55ltaS-gfp-ltaSS218P integrated in strain ANG1575; CamR Lab strain collection 
ANG 2398 pCL55iTET integrated in strain ANG 1575; CamR Lab strain collection 
ANG 2866 pCL55p700ltaS-lacZ integrated in strain ANG 113; CamR Lab strain collection 
ANG 2867 pCL55p473ltaS-lacZ integrated in strain ANG 113; CamR Lab strain collection 
ANG 2868 pCL55p400ltaS-lacZ integrated in strain ANG 113; CamR Lab strain collection 
ANG 2869 pCL55p300ltaS-lacZ integrated in strain ANG 113; CamR Lab strain collection 
ANG 2870 pCL55p200ltaS-lacZ integrated in strain ANG 113; CamR Lab strain collection 
ANG 2871 pCL55p100ltaS-lacZ integrated in strain ANG 113; CamR Lab strain collection 
ANG 2961 pCL55pΔ400-30ltaS-lacZ integrated in strain ANG 314; AmpR This study 
ANG 2962 pCL55pΔ294-30ltaS-lacZ integrated in strain ANG 314; AmpR This study 
ANG 2963 pCL55pΔ294ltaS-lacZ integrated in strain ANG 314; AmpR This study 
ANG 2964 pCL55p700ltaS-lacZ integrated in strain ANG 1575; CamR This study 
ANG 2965 pCL55p473ltaS-lacZ integrated in strain ANG 1575; CamR This study 
ANG 2966 pCL55p400ltaS-lacZ integrated in strain ANG 1575; CamR This study 
ANG 2967 pCL55p300ltaS-lacZ integrated in strain ANG 1575; CamR This study 
ANG 2968 pCL55p200ltaS-lacZ integrated in strain ANG 1575; CamR This study 
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ANG 2969 pCL55p100ltaS-lacZ integrated in strain ANG 1575; CamR This study 
ANG 2970 pCL55p700ltaS-lacZ integrated in strain ANG 467; CamR This study 
ANG 2971 pCL55p473ltaS-lacZ integrated in strain ANG 467; CamR This study 
ANG 2972 pCL55p400ltaS-lacZ integrated in strain ANG 467; CamR This study 
ANG 2973 pCL55p300ltaS-lacZ integrated in strain ANG 467; CamR This study 
ANG 2974 pCL55p200ltaS-lacZ integrated in strain ANG 467; CamR This study 
ANG 2975 pCL55p100ltaS-lacZ integrated in strain ANG 467; CamR This study 
ANG 2976 pCL55pΔ400-30ltaS-lacZ integrated in strain ANG 1575; CamR This study 
ANG 2977 pCL55pΔ294-30ltaS-lacZ integrated in strain ANG 1575; CamR This study 
ANG 2978 pCL55pΔ294ltaS-lacZ integrated in strain ANG 1575; CamR This study 
ANG 2979 pCL55pΔ400-30ltaS-lacZ integrated in strain ANG 1575; CamR This study 
ANG 2980 pCL55pΔ294-30ltaS-lacZ integrated in strain ANG 1575; CamR This study 
ANG 2981 pCL55pΔ294ltaS-lacZ integrated in strain ANG 1575; CamR This study 
ANG 3018 pCL55pltaS-gfpP7-ltaSS218P integrated in strain ANG 314; CamR This study 
ANG 3019 pCL55pltaS-gfpP7-linker-ltaSS218P integrated in strain ANG 314; 
CamR 
This study 
ANG 3020 pCL55iTET-gfpP7-ltaSS218P integrated in strain ANG 314; CamR This study 
ANG 3021 pCL55iTET-gfpP7-linker-ltaSS218P integrated in strain ANG 314; 
CamR 
This study 
ANG 3022 pCL55pltaS-gfpP7-ltaSS218P integrated in strain ANG 1575; CamR This study 
ANG 3023 pCL55pltaS-gfpP7-linker-ltaSS218P integrated in strain ANG 1575; 
CamR 
This study 
ANG 3024 pCL55iTET-gfpP7-ltaSS218P integrated in strain ANG 1575; CamR This study 
ANG 3025 pCL55iTET-gfpP7-linker-ltaSS218P integrated in strain ANG 1575; 
CamR 
This study 
ANG 3026 pCL55pltaS-gfpP7-ltaSS218P integrated in strain ANG 2505; CamR This study 
ANG 3027 pCL55pltaS-gfpP7-linker-ltaSS218P integrated in strain ANG 2505; 
CamR 
This study 
ANG 3028 pCL55iTET-gfpP7-ltaSS218P integrated in strain ANG 2505; CamR This study 
ANG 3029 pCL55iTET-gfpP7-linker-ltaSS218P integrated in strain ANG 2505; 
CamR 
This study 
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Table 2 - Primers used in this study 
 
 
Number Primer Sequence 
ANG 317 3-KpnI-SAV719 GGGGTACCCCGAGTTCGTGTTTAAATATTATTTTTTAG 
ANG 319 3-BglII-SAV719 GAAGATCTCCGAGTTCGTGTTTAAATATTATTTTTTAG 
ANG 817 pLKC480 rev (LacZ) GCCTCTTCGCTATTACGCCAGCTGG 
ANG 1047 5-KpnI-P473-LtaS GGGGTACCTATTTGGTACGTAGCTCATACTCG 
ANG 1048 5-KpnI-P400-LtaS GGGGTACCTTTTATCTGCGAAATGTATCATTTTCTAATTC 
ANG 1049 5-KpnI-P300-LtaS GGGGTACCATTAATTGAGCTATGCTTATTATTAC 
ANG 1050 5-KpnI-P200-LtaS GGGGTACCGTTGTAGCCCAAAATACTTGTTAAATC 
ANG 1051 5-KpnI-P100-LtaS GGGGTACCAACTTTTAAACGCACTTATTAATTAAC 
ANG 1052 3-Biotin-Sal-LtaS-3AA Biotin-ACGCGTCGACTGAACTCATGATTCTTTCCCCCG 
ANG 1058 5-KpnI-P700-LtaS GGGGTACCCTATTATCCTATTAAATGATCATTATACGC 
ANG 1232 3-Upstr-RM -400 to 30 TTAGATAATAAATCACAGTATTATTTCATTATACATTAGG 
ANG 1233 5-Down-RM -400 to 30 AATAATACTGTGATTTATTATCTAAATAACGG 
ANG 1234 3-Upstr-RM -294 to 30 TTAGATAATAAATGCATAGCTCAATTAATAAATATAGAG 
ANG 1235 5-Down-RM -294 to 30 ATTGAGCTATGCATTTATTATCTAAATAACGG 
ANG 1236 3-Upstr-RM P294 CAATTAATACCACACGAGTAATTTTAGTCAAAATT 
CAAG 
ANG 1237 5- Down-RM P294 ATTACTCGTGTGGTATTAATTGAGCTATGCTTATTA 
TTAC 
ANG 1334 5’-EcoRI-pltaS for CCGGAATTCGGAATAGAATATAGAATGCAATTAG 
ANG 1337 SacII-linker-LtaS for GGCCGCGGCTAAAGAAGCTGCCGCAAAAAGTTCACA 
AAAAAAGAAAATTAGTC 
ANG 1697 3-pltaS GFPmut2 TCCTTTACTCATGATTCTTTCCCCCGTTATTTAG 
ANG 1698 5-pltaS GFPmut2 GGGGAAAGAATCATGAGTAAAGGAGAAGAACTTTTC 
ACTGG 
ANG 1699 3-GFPmut2-LtaS TTTTTGTGAACTTTTGTATAGTTCATCCATGCCATGTG 
ANG 1700 5-GFPmut2-LtaS GAACTATACAAAAGTTCACAAAAAAAGAAAATT 
AGTCTTTTTGC 
ANG 1701 3-GFPmut2-linker-SacII TCCCCGCGGCTTCTTTCGCAGCTGCTTCTTTGTATAG 
TTCATCCATGCCATGTGTAATC 
ANG 1702 5-AvrII-LtaS rbs-
GFPmut2 
CCGCCTAGGCTAAATAACGGGGGAAAGAATCATG 
AGTAAAGGAGAAGAACTTTTCACTGG 
 
Restriction sites are underlined in the primer sequences. 
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3. Results  
3.1. Cellular functions of LTA 
3.1.1. LTA is required for efficient incorporation of D-alanines into 
WTA 
The DltABCD proteins are responsible for D-alanylation of LTA (Fischer, 
1994; Neuhaus et al., 1996; Perego et al., 1995) and it was found that in a dlt operon 
mutant D-alanylation is abolished in both, LTA and WTA (Perego et al., 1995). 
Furthermore it was found when using [
14
C]-alanine that when the radioactivity is lost 
from the LTA fraction it increases in the WTA fraction (Haas et al., 1984; Koch et al., 
1985), which would indicate that D-Ala-LTA acts as the donor of D-alanine residues for 
WTA.  
In order to further investigate the possibility that D-Ala-LTA is the donor for D-
alanines on WTA, the D-alanine content in WTA was determined in an LTA negative 
(RN4220Δspa ΔltaS) S. aureus strain (4S5) (Corrigan et al., 2011). This strain is able to 
grow in the absence of LTA almost normally due to second site suppressor mutations 
that result in increased levels of c-di-AMP (Corrigan et al., 2011). A whole genome 
sequence analysis was previously performed on strain 4S5, which revealed that this 
strain contains an intact dlt operon (Corrigan et al., 2011). The wild-type S. aureus 
control strain (RN4220Δspa) and LTA negative 4S5 strain were grown to mid-log 
phase and cell wall material containing WTA isolated as described in section 2. 
Materials and Method. WTA was hydrolysed from peptidoglycan in acidic conditions to 
retain the D-alanine modifications. The purified WTA material was subsequently 
analysed by 1D proton NMR. Clear signals derived from protons from the D-alanine and 
N-acetyl-glucosamine (GlcNAc) modifications were observed in WTA samples isolated 
from the wild-type strain (Figure 5). As previously reported (Bernal et al., 2009), the 
ratio of the signal from the three methyl groups protons of D-Ala at 1.6 ppm to GlcNAc 
at 2.1 ppm was 0.54 ± 0.08 for WTA isolated from a wild-type strain (Figure 5). On the 
other hand, the reduction in the D-alanine specific signal in WTA isolated from the LTA 
negative strain was drastic and statistically significant, yielding a D-Ala to GlcNAc ratio 
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of 0.11 ± 0.01 (Figure 5). These results support a model whereby D-Ala-LTA acts as the 
donor of D-alanines for WTA.  
 
 
 
Figure 5 - NMR analysis of WTA isolated from WT and LTA negative S. aureus strains. S. aureus 
strains RN4220Δspa (WT) and 4S5 (LTA negative) where grown to mid-log phase and WTA purified as 
described in the section 2. Materials and Methods. Six mg of dried WTA were suspended in 99.99 % D2O 
and 1-D proton spectra acquired at 600 MHz. The experiment was performed in triplicate and 
representative spectra are shown. The ratio of the D-Ala to GlcNAc signal is 0.54 ± 0.08 for WTA 
isolated from a WT strain and 0.11 ± 0.01 for WTA isolated from the LTA negative strain. A 2-tailed 
unequal variance T-test indicated a p<0.01 indicating statistically significant differences. Peaks are 
annotated as previously described (Bernal et al., 2009) and full spectra are shown in Annex 1.  
 
 
3.1.2. Depletion of LTA is bactericidal 
 
The LTA synthase enzyme LtaS is responsible for the synthesis of the LTA 
polyglycerolphosphate (PGP) chain in S. aureus (Gründling & Schneewind, 2007b). 
Using an inducible ltaS strain, it was previously shown that this enzyme is essential for 
bacterial growth as in the absence of the inducer cells are no longer able to grow 
(Gründling & Schneewind, 2007b). However, it is not known whether the cells are no 
longer able to grow but are still viable (bacteriostatic effect), or if the cells lose their 
viability and are in fact dying in the absence of LTA (bactericidal effect). Here it was 
further studied if the absence of LTA is bacteriostatic or bactericidal.  
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In order to do this the wild-type S. aureus strains RN4220 and LAC* and the 
isogenic inducible ltaS strains RN4220-iltaS and LAC*-iltaS were grown overnight in 
TSB medium. The next day, the cultures were washed with fresh medium and back 
diluted into TSB and grown for 6 h at 37°C. In the case of the inducible ltaS strains, 
cultures were grown with and without inducer. Samples were taken every 2 h, 
normalised for OD600nm readings (Figure 6A, 6B), stained with the live/dead stains and 
analysed by microscope (Figure 6C). The live/dead microscopic viability assay uses two 
stains that differ in their ability to penetrate cells: SYTO 9, a green-fluorescent nucleic 
acid stain that penetrates all cells in a population, the ones with intact membranes 
(living cells) and the ones with damaged membranes (dead cells) and propidium iodide, 
a red-fluorescent nucleic acid stain that is only able to penetrate dead cells and, when 
used with SYTO 9, reduces the green fluorescence. Therefore, living cells are stained 
green and damaged cells are stained red. 
The growth curves seem to indicate that the uninduced RN4220-iltaS ceases to 
grow earlier than the uninduced MRSA strain LAC*-iltaS (Figures 6A, 6B). However, 
the live/dead assay shows similar results for both strains (Figure 7A, 7B). As seen in 
Figure 6C, the majority of wild-type cells, as well as RN4220-iltaS grown with IPTG 
remain alive during the 6 h of growth. However, in the absence of IPTG, cell death is 
observed at both the 4 h and 6 h time points. It is important to note that, although all the 
samples were normalised for OD600nm readings, most of the cells are enlarged and 
misshaped especially after 4 h of IPTG removal in the iltaS strain (Gründling & 
Schneewind, 2007b). This may influence the optical density and in this way influence 
the number of cells per field. The images presented correspond to the results obtained in 
the S. aureus RN4220 strains, but similar results were observed using LAC* strains.   
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Figure 6 – Determination of bacterial viability using a live/dead staining assay. (A, B) Bacterial 
growth curves. The S. aureus WT strains RN4220 or LAC*, and the inducible ltaS strains RN4220-iltaS 
or LAC*-iltaS were grown overnight, washed and back diluted 1:400 into fresh medium with or without 
IPTG for the inducible strains. OD600nm readings were determined and plotted every 2 h. The experiment 
was performed in triplicate and representative growth curves are shown. (C) Microscopic images for 
RN4220 and RN4220-iltaS samples. Samples were taken every 2 h, normalised for OD600nm readings 
and stained with a 1:1 mixture of SYTO 9 (green) and propidium iodide (red) from the Live/Dead 
Baclight Bacterial Viability Kit. A Nikon Eclipse E600 microscope equipped with a Nikon Digital 
DXM1200 camera and Digital Sight ACT-1 software was used to acquire the images. In a population 
living cells are stained green, while dead cells are stained red. The experiment was performed in triplicate 
and representative images are presented. Scale bar = 50μm.  
 
 
After microscopic observation, three fields of each sample in each experiment 
were analysed using Image J software in order to quantify the results. The cells 
observed by phase contrast were considered the number of total cells in order to 
calculate percentages (Figure 7A, 7B). The quantification confirmed what was observed 
in the microscopy images: in the LtaS depleted strains there is a significant decrease in 
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living cells from the 4 h time point, while the wild-type and induced strains maintain a 
high level of living cells. 
These results indicate that the absence of LTA is indeed bactericidal for S. 
aureus cells for both the laboratory strain RN4220 and the MRSA strain LAC*, 
confirming that LtaS activity is necessary for bacterial survival.  
 
 
 
 
 
 
 
 
 
 
Figure 7 - Quantification of the live/dead assay. In each experiment cells from three different fields 
were counted. Cells from the phase contrast images were considered the total number to calculate the 
percentage of living cells. The assay was performed in triplicate and the mean and standard deviation are 
shown in the graph. A 2-tailed unequal variance T-test analysis was performed and results that have 
statistically significant differences comparing with the WT strain are indicated with asterisks (*p<0.01; 
**p<0.05).  
 
 
3.1.3. Depletion of LTA causes membrane depolarisation 
 
In the cell envelope, the membrane potential is an important determinant in 
maintaining the charge equilibrium at the surface, since it regulates the binding of ions 
(Neuhaus & Baddiley, 2003). Given the zwitterionic properties of LTA, it could be 
expected that its absence would also have an influence on the membrane potential. 
Furthermore, it was shown by electron microscopy that in the absence of LtaS cells 
become misshaped and have deformed membranes (Gründling & Schneewind, 2007b). 
Also, as referred to in the previous section, cells actually die in the absence of LtaS, 
which would be expected to be reflected in membrane depolarisation. 
Therefore it was decided to investigate how the membrane potential changes in 
the absence of LtaS. For this purpose, and similarly to the procedure used for the 
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live/dead assay, the wild-type S. aureus strains RN4220 and LAC*, and the inducible 
ltaS strains RN4220-iltaS and LAC*-iltaS were grown overnight in Mueller-Hinton 
broth. The following day the cultures were washed in fresh medium and back diluted 
into medium with or without inducer for the inducible ltaS strain. The strains were 
grown for 6 h taking samples every 2 h. The samples were washed in a glucose-
containing buffer, suspended in the same buffer with additional KCl and diluted to a 
final OD600nm of 0.05. In order to measure changes in the membrane potential, the 
samples were incubated with 3,3’-dipropylthiadicarbocyanine iodide, [DiSC3(5)], a 
positively charged dye. Under normal conditions, where the membrane potential is 
negative inside, the dye accumulates inside the cell, resulting in the formation of non-
fluorescent aggregates. On the other hand, when there is membrane depolarisation the 
dye does not efficiently penetrate the cell, which results in an increase in fluorescence, 
and the opposite occurs when there is membrane hyperpolarisation (Sip et al., 1990). As 
a positive control, the wild-type strains were incubated with nisin, an antimicrobial that 
is known to form pores in the membrane and thereby abolishes the membrane potential 
(Li et al., 2009).   
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Figure 8 – Membrane potential changes in RN4220-iltaS (A) and LAC*-iltaS (B). The S. aureus WT 
strains RN4220 or LAC*, and the inducible strains RN4220-iltaS or LAC*-iltaS were grown overnight, 
washed and back diluted 1:400 into fresh medium with or without IPTG for the inducible strains. Samples 
were taken every 2 h and normalised for OD600nm readings in buffer containing glucose and KCl. The 
samples were incubated with the dye DiSC3(5) to allow dye uptake and fluorescence quenching. For the 
positive controls, the WT strains were incubated with nisin. The fluorescence was measured at an 
excitation wavelength of 622 nm and emission wavelength of 670 nm. A 2-tailed unequal variance T-test 
analysis was performed and results that have statistically significant differences comparing with the WT 
are indicated with asterisks (* p<0.01; ** p<0.05).  
 
 
At the 2 h time point there is a low level of fluorescence in both wild-type 
strains RN4220 and in LAC*, and a low level of fluorescence is also observed for the 
inducible ltaS strains with inducer (Figure 8), indicating that this is the fluorescence 
detected when the membrane potential is maintained at its wild-type level. However, the 
inducible ltaS strains without IPTG show a slight increase but this is not statistically 
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significant (Figure 8). This is in agreement with the live/dead assay, where only a slight 
decrease in the percentage of living cells is observed after 2 h of growth without 
inducer. At the 4 h time point there are differences between both strains: the laboratorial 
strain RN4220-iltaS without inducer showed a significant increase in fluorescence, 
indicating membrane depolarisation, while for the MRSA strain LAC*-iltaS there is 
also an increase in fluorescence but this is less significant and more variable (Figure 8). 
This may indicate that it takes longer in the MRSA strain for the membrane potential to 
change in the absence of LTA. At the 6 h time point similar results were obtained for 
both strains and a significant increase in fluorescence for the LtaS depleted strains, 
indicating membrane depolarisation (Figure 8).  
These results indicate that in the absence of LTA, membrane depolarisation 
occurs, which happens at the same time point as when there is a significant increase in 
the number of dead cells (see section 3.1.2. Depletion of LTA is bactericidal). 
 
3.1.4. LtaS localisation studies 
 
In S. aureus it has been shown that in the absence of LtaS cells display aberrant 
positioning of the cell division septa (Gründling & Schneewind, 2007b). Furthermore, 
in B. subtilis it was previously shown that an LtaS homologue localises at the cell 
division site and the deletion of ltaS in B. subtilis leads to mislocalisation of FtsZ, a key 
cell division protein (Schirner et al., 2009). These data indicate that LtaS may localise 
at the division septum in S. aureus, which may suggest a role in cell division. In order to 
observe the localisation of LtaS in S. aureus, fusions between the “superfast-folding” 
version of the green fluorescent protein (GFP) (Fisher & DeLisa, 2008) and LtaSS218P, 
the less cleaved version of LtaS (Wörmann et al., 2011b) were produced (Figure 9).  
LtaS has five transmembrane helices linked to an extracellular enzymatic 
domain. The extracellular domain (eLtaS) is cleaved by the signal peptidase SpsB in the 
linker region after an AXA motif and released into the culture supernatant (Wörmann et 
al., 2011b). It has been previously shown that the substitution of the serine residue 
following the cleavage site with a proline (LtaSS218P) reduces the level of LtaS cleavage, 
resulting in higher amounts of full-length protein (Wörmann et al., 2011b). The 
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cleavage of LtaS would lead to the rapid degradation of the fluorescent protein fusion 
and accumulation of the cleaved product in the cytoplasm. Fluorescent protein fusions 
to wild-type LtaS were previously constructed and resulted in high cytoplasmic 
fluorescence (Reichmann et al., unpublished results). Therefore, to minimise the 
degradation of the fusion proteins, GFP was fused to the LtaSS218P variant (Wörmann et 
al., 2011b). Given the fact that the C-terminal end of LtaS is localised on the outside of 
the membrane, only N-terminal fusions were designed. Furthermore, in order to 
improve the fluorescence signal, LtaSS218P was fused to a “superfast-folding” variant of 
GFP (named GFPP7). The “superfast-folding” variant of GFP is an improved variant of 
GFPmut2 (Cormack et al., 1996) which has additional point mutations and the protein 
displays increased folding kinetics, slower unfolding and increased stability during 
equilibrium unfolding (Fisher & DeLisa, 2008).  
Four different fusions were constructed: with and without a 3x EAAAK amino 
acid linker region between GFPP7 and LtaSS218P, and expressed either from the native 
ltaS promoter or the Atet inducible iTET promoter (Figure 9). The introduction of the 
EAAAK linker would be expected to provide space and flexibility between GFPP7 and 
LtaSS218P, perhaps improve protein folding and stabilise the fluorescent protein (Arai et 
al., 2001). Furthermore, the utilisation of an inducible promoter allows control of the 
expression levels of the fusion proteins. However the utilisation of the native promoter 
provides more similar expression levels to those obtained under natural conditions. 
These fusions were cloned into the integration vector pCL55, enabling stable expression 
of the fusions from the chromosome after integration of the vector into the lipase gene 
locus geh. All plasmids were introduced into S. aureus RN4220Δspa and subsequently 
transduced into LAC* and LAC*-iltaS for fluorescence microscopy and functionality 
studies. 
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Figure 9 - Schematic representation of fluorescent protein fusions to the S. aureus LtaSS218P protein. 
The fluorescent protein GFPP7 was fused to the N-terminus of a less cleaved version of LtaS (LtaSS218P) 
under the LtaS native promoter control (A, B) or the Atet inducible iTET promoter control (C, D). In two 
of the constructions a 3x EAAAK amino acid linker region was cloned between LtaS and the fluorescent 
protein GFP (B, D). Plasmid names and S. aureus strain numbers are given on the right. 
 
 
 Once the GFPP7 fusions to LtaSS218P were made, it was important to determine 
whether the fusion proteins were functional. In order to do this, each construction was 
introduced into the inducible ltaS strain, LAC*-iltaS. Therefore, in the absence of IPTG, 
only strains expressing a functional ltaS gene are able to grow and produce LTA (Figure 
10A). The S. aureus LAC*-iltaS strains with the different GFPP7 constructs were then 
grown in absence of IPTG and constructions with Atet inducible iTET promoter were 
grown in the absence or presence of Atet. The LAC*-iltaS strain grown in the absence 
of IPTG was used as the negative control, while the LAC* wild-type strain was used as 
a positive control since it produces wild-type levels of LTA.  
Growth was restored in all four strains expressing the fusion proteins, and 
although at 6 h they did not reach the wild-type level, at 8 h they were all like the wild-
type strain (Figure 10B). Of note, the fusions under the control of the Atet inducible 
iTET promoter, even in the absence of inducer were able to partially restore growth, 
indicating that expression from this system is “leaky”.  
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Figure 10 - LtaS complementation analysis as assessed by LTA and LtaS western blot analysis and 
bacterial growth complementation analysis. (A) Schematic representation of the S. aureus strains 
LAC*-iltaS. The chromosomal copy of ltaS is expressed from the IPTG inducible spac promoter. GFPP7 
fusions cloned into pCL55 that integrates into the chromosome in the lipase gene, geh, and are under the 
native ltaS or the Atet inducible iTET promoter control. In the absence of IPTG, LTA is no longer 
produced and cells cease to grow, unless complemented with a functional copy of ltaSS218P from pCL55. 
(B) Bacterial growth curves. The S. aureus LAC*-iltaS strains were grown in absence of IPTG, with the 
exception of the LAC*-iltaS control strain without any fusion that was grown the in absence (-) or 
presence (+) of 1mM IPTG. The constructions with Atet inducible iTET promoter were grown in the 
absence (-) or presence (+) of 100 ng/ml Atet. At the 4 h all strains were back-diluted 1:100. (C) 
Detection of LTA production by western blot. S. aureus LAC* and LAC*-iltaS strains were grown in 
the same way as for the bacterial growth curves. At the 4 h time-point samples were prepared for western 
blot analysis and the LTA detected using a mouse monoclonal LTA antibody and HRP-conjugated anti-
mouse IgG antibody at 1:5000 and 1:10000 dilutions, respectively (see section 2.Materials and Methods). 
(D) Detection of LtaS production by western blot. S. aureus LAC* and LAC*-iltaS strains were grown 
in the same way as for the bacterial growth curves. At the 4 h time-point samples were prepared for 
western blot analysis and LtaS detected using a rabbit polyclonal LtaS antibody and HRP-conjugated 
anti-rabbit IgG antibody at 1:20000 and 1:10000 dilutions, respectively (see section 2. Materials and 
Methods section). The full-length fusions are indicated with an asterisk (*). The experiments were 
performed once. 
 
 
At the 4 h time point, samples were prepared for LTA and LtaS analysis by 
western blot. In addition, LAC* strains containing the empty pCL55iTET vector or 
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GFPP7-LtaSS218P fusions were grown for 4 h and prepared in a similar manner.  As 
expected, all the LAC* strains with the fusion protein had a wild-type level of LTA 
since in this strain ltaS is produced from its native locus, however, that was not 
observed for the LAC*-iltaS strains where none of the strains expressing the fusion 
proteins were able to produce wild-type levels of LTA: the strain containing pCL55ltaS-
gfpP7-ltaSS218P did not produce detectable amounts of LTA, while the strains containing 
pCL55ltaS-gfpP7-linker-ltaSS218P, pCL55iTET-gfpP7-ltaSS218P and pCL55iTET-gfpP7-
linker-ltaSS218P produced LTA but not at the wild-type levels (Figure 10C). This 
indicates that the GFPP7-LtaSS218P fusion is partially functional when expressed under 
the control of the inducible promoter, while the GFPP7-linker-LtaSS218P is partially 
functional when expressed from the native and inducible promoters, however, 
producing higher levels of LTA under the control of the inducible promoter. Together 
with the bacterial complementation growth curves, these results indicate LTA is being 
produced at levels that although not wild-type, can still complement growth, indicating 
that the fusions are partially functional. 
 In order to use these fluorescent protein fusions in microscopy experiments, the 
full-length fusions need to be expressed. Therefore, western blot analysis was also 
performed and the LtaS protein detected using a rabbit polyclonal LtaS antibody. The S. 
aureus LAC* strain containing the empty vector pCL55iTET was used as a negative 
control, while the LAC* strain expressing the GFP-LtaSS218P under the native promoter 
control, previously constructed and analysed in the laboratory, was used as a positive 
control. All four strains were able to express the full-length fusions in the LAC* and 
LAC*-iltaS strains (Figure 10D).  
Next, the localisation of the fusion proteins was assessed by fluorescence 
microscopy. From studies that previously took place in our laboratory it was already 
known that the resolution of the images obtained at Imperial College London would be 
too low for analysis. Therefore, the strains were sent to Dr. Mariana Pinho's laboratory 
at the Instituto de Tecnologia Química e Biológica, a research group that has localised 
cell division proteins by fluorescence microscopy in S. aureus, and images were taken 
by Dr. Nathalie Reichmann. In this analysis, all strains were grown to mid-exponential 
phase, mounted on a 1.2 % PBS agarose slide and observed using a Zeiss Axio 
Observer Z1 microscope equipped with a Photometrics CoolSNAP HQ2 camera (Roper 
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Scientific) (see section 2. Materials and Methods). The image acquisition was 
performed with this microscope using Metamorph software. The preliminary data 
indicates that LtaSS218P displays concentrated fluorescence at the septum (Figure 11), 
suggesting that LtaS may localise mainly at the site of cell division in S. aureus, in 
agreement with studies in B. subtilis (Schirner et al., 2009).  
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11 - Localisation of LtaS in S. aureus as assessed by fluorescence microscopy. The S. aureus 
LAC* strains with the different fusions were grown to mid-exponential phase and suspended in PBS. 
Cells were mounted on a 1.2% PBS agarose slide and subsequently observed using a Zeiss Axio Observer 
Z1 microscope equipped with a Photometrics CoolSNAP HQ2 camera (Roper Scientific). Images were 
acquired using Metamorph software. Phase contrast and GFP images are shown at the left and right, 
respectively, and the arrows point to the septum. Scale bar = 1 µm. This experiment was performed once. 
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3.2. Regulation of ltaS expression and LTA production 
  
3.2.1. Mapping and activity analysis of two ltaS promoters  
 
Although the reactions and enzymes involved in LTA synthesis are known, how 
this process is regulated is still mainly unknown. As LtaS is the key enzyme necessary 
for LTA synthesis (Gründling & Schneewind, 2007b), it would be of interest to study its 
promoter or cis elements in order to understand the regulation of LTA synthesis. 
Previously in our laboratory the ltaS promoters were mapped using PCR Rapid 
Amplification of cDNA Ends (RACE) and primer extension. Both techniques enabled 
the identification of two transcriptional start sites 408 and 294 bases in front of the start 
codon of the ltaS gene (hereafter named P1 and P2 promoter, respectively) in S. aureus 
strains RN4220 and Newman (Figure 12) (Gründling, unpublished results). These 
results indicate a presence of a long 5’ untranslated region (UTR) between the 
promoters and the initiation codon of ltaS, which is unusual and can indicate an intricate 
regulatory network.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12 – Schematic representation of ltaS promoter region. Previously, two transcriptional start 
sites 408 and 294 bases in front of ltaS gene in S. aureus strains RN4220 and Newman were identified by 
A. Gründling (unpublished results) using PCR RACE and primer extension techniques.   
 
 
In order to study the functionality of the two promoters and to further 
understand the transcriptional regulation of ltaS in S. aureus, a series of different 
promoter fusions to the reporter gene lacZ were constructed. Different portions of the 
ltaS UTR were fused to the lacZ gene using the plasmid pCL55iTET-lacZ (Figure 13A). 
The gene lacZ works as a reporter gene that enables the evaluation of expression from 
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the promoters of interest. Fragments with 700 bp, 473 bp, 400 bp, 300 bp, 200 bp and 
100 bp from the ltaS start codon were amplified from S. aureus chromosomal DNA and 
then inserted into pCL55iTET-lacZ upstream of lacZ, and transformed into the E. coli 
XL1 Blue strain. The resulting plasmids were then introduced into S. aureus strains 
RN4220, LAC* and Newman. The S. aureus RN4220 strain with the empty plasmid 
pCL55iTET was used as a negative control, while the strains bearing the largest insert 
(700 bp) were used as a positive control for ltaS-driven lacZ expression (Figure 13B).  
 The β-galactosidase activity was evaluated and the results obtained indicate that 
the constructs with 700 bp, 473 bp and 400 bp from the upstream region of ltaS fused to 
lacZ have higher level of expression, compared to the constructs with 300 bp, 200 bp 
and 100 bp (Figure 13B). This indicates that in the absence of the P1 promoter there is 
still expression, but when the P2 promoter is deleted there is no longer expression. This 
may suggest that the P2 promoter is not only essential but also sufficient for expression. 
Of note, in all three background strains there is an increase in activity in the fusion 
containing 473 bp when compared with the construct with the largest insert, however 
this difference is not statistically significant.  
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Figure 13 - Mapping and activity analysis of two ltaS promoters as assessed by lacZ fusions and β-
galactosidase activity. (A) Schematic representation of the lacZ fusion constructs. The ltaS UTR 
region was cloned into pCL55iTET-lacZ. Six different constructions were made, where fragments with 
700 bp, 473 bp, 400 bp, 300 bp, 200 bp and 100 bp from ltaS UTR were fused to lacZ. (B) 
Determination of β-galactosidase activity. S. aureus strains RN4220 (i), Newman (ii) and LAC* (iii) 
containing pCL55iTET with the different fusions and the S. aureus strain RN4220Δspa containing the 
empty vector pCL55iTET (negative control) were grown for 4 h at 37°C and samples were prepared as 
described in the section 2. Materials and Methods. The assay was performed in triplicate and the mean 
and standard deviation are shown. Activity is given as Units per OD600nm. A 2-tailed unequal variance T-
test analysis was performed and values that have statistically significant differences comparing with the 
full-length UTR fusion (P700 bp) are indicated with asterisks (* p<0.01; ** p<0.05). 
 
 
 
Given these results and to try to understand the role of the region between the P2 
promoter and the translational start site and between both promoters, additional fusions 
were constructed. Firstly, a construction lacking the region from -400 bp to -30 bp 
(PΔ400-30) (the numbers are relative to the ltaS start codon) was made to determine the 
role of the region between the P1 promoter and the transcriptional start site. A 
construction with a deletion of the region from -294 bp to -30 bp (PΔ294-30) was 
designed to investigate a possible function of the region between the P2 promoter and 
the transcriptional start site. Lastly, a construction where the P2 promoter was mutated 
(PΔ294) by modifying the conserved -10 region was used to investigate if there is 
expression even in the absence of the P2 promoter but in the presence of only the P1 
promoter (Figure 14A). Once again different fragments were amplified from S. aureus 
chromosomal DNA, assembled by SOE PCR in order to obtain the necessary deletions 
and inserted into pCL55iTET-lacZ. The plasmids were first obtained into the E. coli 
XL1 Blue strain and finally transformed into the S. aureus strains RN4220Δspa, LAC* 
and Newman. The same negative and positive controls were used as in the experiment 
above (Figure 14B). 
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Figure 14 - Mapping and activity analysis of two ltaS promoters using a mutagenesis approach and 
assessed by lacZ fusions and β-galactosidase activity. (A) Schematic representation of the lacZ 
fusion constructs. The ltaS UTR region was fused to lacZ gene and cloned into pCL55iTET-lacZ. Three 
different constructions were made, where fragments with from the 700 bp ltaS UTR were fused to lacZ: a 
fragment with the region between -400 and -30 deleted, a fragment with the region between -294 and -30 
deleted and a third construction with the P2 promoter mutated. (B) Determination of β-galactosidase 
activity. S. aureus strains RN4220Δspa (i), Newman (ii) and LAC* (iii) containing pCL55iTET with the 
different fusions and the S. aureus strain RN4220Δspa containing the empty vector pCL55iTET (negative 
control) were grown for 4 h at 37°C and samples were prepared as described in the Materials and 
Methods section. The assay was performed in triplicate and the mean and standard deviation are shown. 
Activity is given as Units per OD600nm. A 2-tailed unequal variance T-test analysis was performed and 
results that are statistically different from the full-length UTR fusion (P700 bp) are indicated with 
asterisks (* p<0.01; ** p<0.05).  
 
 
The results obtained seem to indicate that when the P2 promoter is deleted or 
mutated there is only a low level of activity even when the P1 promoter is present, as 
can be seen by the low activity in the PΔ400-30 and PΔ294 constructs, where the 
second promoter was deleted or mutated. This means that the P2 promoter is the main 
promoter useful for ltaS expression. Furthermore, when the region between the P2 
promoter and the translational start site is deleted there is still a high level of expression. 
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This may suggest that under these circumstances this region is not important to activate 
expression.  
 
3.2.2. LTA production is reduced under high salt conditions 
 
It has been previously shown that LTA potentially has a role as an 
osmoprotectant under low osmolarity conditions (Oku et al., 2009). Therefore, it was 
decided to investigate S. aureus cell viability in medium with different salt 
concentrations and the effect of altering ltaS expression and consequently LTA 
production. This was assessed using the inducible ltaS strains since it is known that 
these strains produce reduced amounts of LtaS compared to the wild-type strains 
(Wörmann et al., 2011b), and consequently may resist less to osmotic stress. 
LB medium was used for growth and the salt concentration adjusted by the 
addition of increasing amounts of NaCl.  Since it is known that S. aureus cells can 
survive until approximately 7% of NaCl (Bruins et al., 2007), LB medium containing 
0% to 6% of NaCl was used to perform bacterial growth curves using the wild-type 
strains RN4220 and LAC*. The growth curves were performed by back diluting the 
overnight culture 1:100 into fresh medium and back diluting again after 4 h of growth to 
maintain the cells in exponential growth phase for an extended period of time. 
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Figure 15 – Bacterial growth curves using wild-type and inducible ltaS strains in LB media 
containing a gradient of NaCl concentrations. The S. aureus RN4220 (A) and LAC* (B) inducible and 
wild-type strains were grown in LB media containing 0% to 6% NaCl and for the inducible strains in the 
absence (-) and presence (+) of 1mM IPTG. At the 4 h all strains were back-diluted 1:100. These 
experiments were performed in triplicate. 
 
The results obtained indicate that in a range of 0% to 6% NaCl the wild-type 
strains RN4220 and LAC* both slow down their growth as the salt concentration 
increases. At 5% NaCl concentration both wild-type strains have a reduced growth rate 
and enter in stationary phase after growing for 4 h. Using the inducible strains there is 
also a growth reduction as the salt concentration increases even in the strains with 
inducer, which starts to occur at a lower NaCl concentration (around 2%) for both 
RN4220-iltaS and LAC*-iltaS strains (Figure 15). This may happen because the 
inducible ltaS strains produce less LtaS than the wild-type strains (Wörmann et al., 
2011b). This would also be reflected in a reduction of LTA production and a 
consequent reduction in resistance to high osmolarity. 
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In order to assess LTA production under these conditions, LTA was detected in 
samples isolated at the 4 h time point by western blot using a monoclonal anti-LTA 
antibody. Consistent with what was observed in the bacterial growth curves, as the 
NaCl percentage in the media increases a reduction in LTA production was observed for 
the iltaS strains and the wild-type strains. This reduction was observed at higher 
concentrations for the wild-type strains when compared with the iltaS strains (Figure 
16A) and seems to be more drastic for the LAC* strains than for the RN4220 strains.  
Given the fact that LtaS is produced in the iltaS strains under the control of spac 
promoter, it could be hypothesised that these observations are due to an effect of NaCl 
on this promoter, causing alterations in LTA production. To analyse this possibility, the 
strains were grown under the same conditions and the protein LtaS detected by western 
blot using a polyclonal anti-LtaS antibody. LtaS is known to be cleaved at the linker 
region between the N-terminal transmembrane helices and the C-terminal extracellular 
domain (eLtaS), and eLtaS is released into the supernatant, though also retained within 
the whole cell fraction. On the other hand, full length LtaS is only detected in the whole 
cell fraction (Lu et al., 2009; Wörmann et al., 2011b) Therefore, a cell fractionation 
technique was employed and the cell fraction analysed. The uninduced iltaS strains 
grown in 0% NaCl and the LTA negative strain 4S5 were used as negative controls. The 
results obtained show that full-length LtaS can be detected in high amounts both in 
wild-type and iltaS strains in RN4220 and LAC* at any salt concentration (Figure 16B). 
In fact, it even seems possible that there is a slight increase in LtaS synthesis when there 
is an increase in NaCl percentage, which is opposite to what was observed for LTA 
production (Figure 16B). 
Together, these results indicate that LTA production is reduced under high salt 
concentrations, which affects bacterial growth and this is possibly due to alterations in 
LtaS enzymatic activity, since LtaS levels are elevated even at high salt concentrations.  
Therefore, a strain with lower levels of LTA seems to not survive salt stress as well as a 
wild-type strain. 
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Figure 16 – LTA and LtaS production under different NaCl concentrations as assessed by western 
blot. (A) Detection of LTA by western blot. The S. aureus RN4220-iltaS and LAC*-iltaS strains were 
grown in absence (-) and presence (+) of 1mM IPTG in LB media containing 0% to 6% NaCl, while the 
RN4220 and LAC* wild-type strains were grown only in the absence of inducer in media with the same 
composition as for the iltaS strains. Samples for western blot analysis were obtained after 4 h of growth. 
LTA was detected using a mouse monoclonal LTA antibody and HRP-conjugated anti-mouse IgG 
antibody at 1:5000 and 1:10000 dilutions, respectively (see section 2.Materials and Methods). (B) 
Detection of LtaS by western blot. S. aureus LAC* and LAC*-iltaS strains were grown in the same way 
as for LTA detection and the LtaS protein detected by western blot using a rabbit polyclonal LtaS 
antibody and HRP-conjugated anti-rabbit IgG antibody at 1:20000 and 1:10000 dilutions, respectively 
(see section 2.Materials and Methods). The full-length protein is indicated with an asterisk (*). The 
experiments were performed in triplicate. 
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4. Discussion and Conclusions 
 
LTA is a zwitterionic polymer that is widely distributed amongst Gram-positive 
bacteria, ranging from Actinobacteria to Firmicutes. Amongst these species emphasis 
has been given to researching LTA in the pathogenic bacteria S. aureus and L. 
monocytogenes and it has also been studied in the model organism B. subtilis 
(Reichmann & Gründling, 2011). The importance of LTA for adherence, host invasion, 
virulence and bacterial growth makes it appealing for further investigation as a 
promising target for new antimicrobials (Collins et al., 2002; Doran et al., 2005; Sheen 
et al., 2010). This study is focused on S. aureus, where many roles for LTA are known, 
including roles in cell division, osmoprotection, regulation of enzymatic activity and ion 
scavenging (Archibald & Baddiley, 1966; Corrigan et al., 2011; Gründling & 
Schneewind, 2007b; Heptinstall et al., 1970; Oku et al., 2009). Most importantly, LTA 
is essential for S. aureus growth and cells depleted of LTA become enlarged prior to 
cell lysis. The LTA synthase enzyme, LtaS, is the key enzyme involved in LTA 
synthesis, since it is responsible for the PGP chain polymerization. In the case of S. 
aureus, only one LTA synthase is encoded on the genome (Gründling & Schneewind, 
2007b). LtaS is therefore essential for bacterial growth, and so until recently, 
investigations of the roles of LTA have been restricted to analysis of mutants 
synthesising the PGP chain, but with altered LTA glycolipid anchors (Fedtke et al., 
2007; Gründling & Schneewind, 2007a; Kiriukhin et al., 2001). However, recent 
construction of a conditional depleted ltaS mutant (Gründling & Schneewind, 2007b) 
and a suppressor strain able to grow without LTA (Corrigan et al., 2011) has enabled 
further investigations on the LTA roles on the cell, which was one of the overall aims of 
this study. Furthermore, the enzymes necessary for LTA synthesis are known but how 
this process is regulated and how this correlates with different growth conditions are 
largely unknown. Therefore, this study aimed to give new insights into the regulation of 
LTA synthesis, focusing on ltaS gene expression. 
A previously proposed role for LTA is that of a donor of D-alanines for WTA. 
LTA D-alanylation is known to be an enzymatically catalysed process involving the Dlt 
proteins. However, a different process was previously proposed for WTA D-alanylation 
based on pulse-chase experiments using [
14
C]-alanine, which demonstrated that 
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radioactive D-alanines are lost from the LTA fraction and increased in the WTA fraction 
(Haas et al., 1984), indicating D-Ala-LTA is a donor for WTA D-alanylation. The 
disruption of the dlt operon results in a lack of D-alanines on both LTA and WTA 
(Perego et al., 1995), but this observation in WTA could be directly due to the absence 
of Dlt proteins or the absence of D-Ala-LTA. Therefore, this mechanism was 
investigated in this study using a recently described S. aureus LTA negative strain with 
an intact dlt operon (Corrigan et al., 2011). The result obtained here showed that the D-
alanine content in WTA is drastically reduced in the absence of LTA (Figure 5), 
providing strong evidence that D-Ala-LTA is indeed the donor for D-Ala-WTA. 
However, these data also indicate that a small amount of D-alanine residues are still 
present in WTA in the LTA-negative strain. This might suggest that WTA polymers 
when on the outer leaflet of the membrane but still linked to the undecaprenyl 
phosphate membrane carrier can serve as an acceptor molecule for D-alanine 
modification by the Dlt system itself. If this is the case, it is likely to only happen 
inefficiently and transiently, though it would be enough to be detected by this method.  
On the other hand, we cannot rule out the possibility that the small degree of D-
alanylation detected in the LTA-negative strain is due to cross contamination during the 
experimental procedure. This could be evaluated using a strain without an essential 
protein for D-alanylation, like DltB, where is known that D-alanylation does not occur 
and observe if the small amount of D-alanine residues would still be detected.  
It is important to note that this result does not elucidate how and where at the 
cell surface the transfer of D-alanine residues from LTA to WTA occurs. D-alanine 
incorporation into WTA may happen when WTA is still linked to its membrane carrier 
or when it is already attached to the peptidoglycan. The occurrence at the membrane 
would be plausible since LTA and WTA are in close proximity. However, these results 
cannot distinguish between cell wall anchored WTA and WTA present at the cell 
membrane and only analysis of the D-alanine content in WTA still linked to the 
predicted undecaprenyl phosphate membrane carrier could answer this question. 
Furthermore, it is still not known if D-alanine transference from LTA to WTA is 
enzymatically catalysed and no proteins have been identified as being involved in this 
process. This unidentified enzyme or enzymatic complex would have to recognise both 
ribitol phosphate and glycerol phosphate, and to incorporate and remove D-alanines 
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from LTA. It is also possible that no enzyme is required for this process. In fact, it was 
already showed that D-alanines can be transferred between LTA molecules without 
requiring ATP, enzymatic activity or any Dlt protein (Childs et al., 1985). 
In conclusion, the results in this study establish a role for LTA as the D-alanine 
donor for WTA, indicating that the D-alanine modification of these two important 
polymers is closely linked. Given the importance of this modification for TAs roles in 
the cell, this may explain their overlapping functions. Additionally, it may also be an 
indication of coordination in synthesis and localisation between both TAs.  
 
The importance of LTA in the cell is unquestionable, as this molecule is 
necessary for growth and cell division in S. aureus. However, the question we wished to 
answer was, if in the absence of LTA, cells only stop growing and enter starvation, 
which is reflected by early entrance into stationary phase (Gründling & Schneewind, 
2007b), or whether the absence of LTA in fact causes such a large disruption to the cell 
that it leads to immediate cell death. For this purpose, and making use of a conditional 
ltaS depleted mutant, a live/dead staining procedure that distinguishes between living 
and dead cells was applied. This experiment showed that in the absence of LTA cells 
are actually dying (Figure 6), indicating that depletion of ltaS is bactericidal for S. 
aureus cells. These data may increase the interest in using LtaS as a possible target for 
new antimicrobials and, in fact, similar results were observed not only in the laboratory 
strain RN4220, but also in the MRSA strain LAC*, where the majority of the cells 
(around 80%) were dead 4 h after the removal of inducer. Moreover, a small molecule 
has already been discovered that works as an antibiotic for Gram-positive bacterial 
species, possibly by targeting LTA synthesis (Richter et al., 2013). This molecule was 
shown not only to inhibit the growth of S. aureus, but also in other Gram-positive 
bacteria that produce polyglycerolphosphate LTA, and it would be interesting to 
investigate whether ltaS depletion is bactericidal in other species.  
 It is also important to note that besides this, the absence of LtaS may also result 
in the accumulation of PG lipid in the membrane. The PG serves as the donor for GroP 
in LTA synthesis by LtaS and it is estimated that the turn over in this reaction is more 
than twice in one bacterial doubling (Koch et al., 1984) but, without LtaS, GroP is no 
longer hydrolysed from PG. This can result in significant changes in the membrane 
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stability causing membrane disruption.  
Furthermore, and given these results, it was also investigated how ltaS depletion 
affects the membrane potential in S. aureus over time and how this could be correlated 
with the time course experiment performed using a live/dead bacterial viability assay. 
The close proximity of LTA to the membrane and its negatively charged PGP chain 
together with the variable degree of D-alanylation, could make this polymer an 
important component in maintaining the charge distribution at the cell surface and in 
cation binding (Hughes et al., 1973). An assay using a membrane potential sensitive dye 
that shows increased levels of fluorescence when there is membrane depolarisation and 
decreased levels of fluorescence when there is membrane hyperpolarisation was used. 
Therefore, changes in the membrane potential due to the absence of LtaS could be 
assessed. Two hours after growth without inducer both uninduced RN4220-iltaS and 
LAC*-iltaS do not display a statistically significant increase in fluorescence (Figure 8). 
Based on the results from the live/dead staining assay, most of the cells (around 90%) 
are still alive at this time point, even in the uninduced strains. These results may 
indicate that the absence of LTA does not cause membrane depolarisation before cell 
death. On the other hand, it is possible that at this point the LtaS protein still present 
from the overnight culture is active and sufficient to maintain LTA production to a level 
that the membrane potential is not affected.  
At the 4 h time point there is a significant increase in fluorescence, indicating 
membrane depolarisation, in the laboratory strain RN4220 and a less significant and 
more variable increase in the MRSA strain LAC*. At this point, however, it is known 
from the live/dead assay that the majority of the cells are dead. Since the live-dead 
assay is actually also detecting membrane depolarisation (propidium iodide is only able 
to enter cells with depolarised membranes), this indicates that although both assays 
show the same trend they still show subtle differences in the timing when the 
depolarisation is occurring. It is important to note that comparing these strains grown in 
the same conditions (Figure 6A, 6B), the non-induced LAC*-iltaS enters growth arrest 
later (after growing for 4 h) when compared with the non-induced RN4200-iltaS strain 
that stops growing after approximately 3 h. These differences may be reflected in the 
variances between the two assays. As the live/dead assay gives an indication at the 
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single cell level, using DiSC3(5) indicates an average between all the cells, which may 
influence the ability to compare both results. 
 Lastly, after 6 h of growth with depleted ltaS, both RN4220 and LAC* display 
increased fluorescence, indicating membrane depolarisation, which at this point is in 
agreement with the results from the live/dead assay, most likely reflecting the elevated 
fraction of dead cells.  
In conclusion, it is now possible to say that the depletion of ltaS results in S. 
aureus cell death, which occurs approximately after 4 h of ltaS depletion. However, 
since the membrane depolarisation correlates with cell death, it is difficult to determine 
whether depletion of ltaS causes alterations in membrane potential prior to cell death.   
 
As referred to above, another essential proposed role for LtaS is in cell division. 
In B. subtilis, UgtP (YpfP homologue) and LtaS were shown to localise in the septum, 
and the absence of LtaS results in delocalisation of FtsZ. (Schirner et al., 2009; Weart et 
al., 2007). Furthermore, in both L. monocytogenes and B. subtilis ltaS mutant strains 
present a filamentous phenotype (Schirner et al., 2009; Webb et al., 2009). Together, 
these data suggest a direct association between LTA synthesis and cell division and in 
order to further investigate this possibility, localisation studies involving the essential 
LTA synthase, LtaS, were performed in S. aureus. To perform these localisation studies 
a “superfast-folding” version of the green fluorescent protein (GFP), GFPP7 (Fisher & 
DeLisa, 2008) was fused to a less cleaved version of LtaS, LtaSS218P (Wörmann et al., 
2011b), and cloned under the native ltaS promoter or under an inducible promoter into a 
single copy chromosomal integration vector (Lee et al., 1991). Integrative vectors 
provide stability in expression levels reducing the variability of the fluorescence signal 
between cells, making results more reliable.  
LtaS is made up of transmembrane helices linked to an extracellular domain, 
which is cleaved by a signal peptidase named SpsB (Wörmann et al., 2011b). 
Therefore, the utilisation of LtaSS218P variant was intended to reduce cleavage and 
subsequently reduce accumulation of cleaved products in the cytoplasm. The GFPP7 
protein was used in order to reduce cytoplasmic fluorescence since this variant of GFP 
has been shown to keep its folded form more stably (Fisher & DeLisa, 2008). It was 
decided to clone the fusion under the expression control of two different promoters, 
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whereby the utilisation of the native promoter results in expression levels similar to the 
wild-type levels, while the inducible promoter allows expression levels to be varied in a 
controlled manner. In addition, the utilisation of an amino acid linker was explored. As 
an alternative to the direct fusion between GFPP7 and LtaSS218P an EAAAK linker 
repeated three times was used. This linker region increases the distance between the two 
proteins, and consequently increases the stability of the protein as well as the possibility 
of it being functional. Furthermore, it was shown previously that two functional proteins 
separated by this linker region had reduced interference with each other (Arai et al., 
2001). 
These choices were made based on previous LtaS-GFP fusions constructed in 
our laboratory that showed very high cytoplasmic fluorescence and high levels of 
protein degradation and cleavage (Reichmann et al., unpublished results). While these 
full-length fusion proteins were detected by western blot analysis (Figure 10), there was 
still some cytoplasmic fluorescence signal (Figure 11), probably due to protein 
degradation. Furthermore, none of the constructed fusions were fully functional, 
because they did not result in wild-type production of LTA (Figure 10). Despite this, it 
is possible to see an accumulation of GFPP7-LtaSS218P at the septum (Figure 11), 
indicating that LtaS possibly localises at the cell division site, and that the PGP 
backbone chain of LTA is mainly produced at the division site in S. aureus. Although 
these are just preliminary results, this supports the proposal of a role of LtaS in cell 
division. Apart from optimising the growth conditions for the microscopy experiment, it 
would also be of interest to study the timing of LtaS localisation during the cell cycle, in 
particular whether localisation occurs at an early stage during the division process or 
only at a late stage. For this, co-localisation studies with known early and late stage 
proteins such as EzrA and PBP4, respectively, would provide further information about 
the role of this protein during cell division. Additionally, it would be of interest to study 
localisation of the remaining proteins involved in LTA synthesis in S. aureus, including 
the proteins responsible the glycolipid anchor synthesis and of the DltABCD proteins 
that are responsible for D-alanylation, and how these different processes in LTA 
synthesis correlate with each other.  
In conclusion, these data indicated that LtaS seems to localise at the cell division 
site in S. aureus. However it should be noted that even if new LTA is only synthesised 
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at the cell division, previous studies using immune electron microscopy indicate that 
LTA in S. aureus is distributed throughout the membrane (Aasjord & Grov, 1980).  In 
addition, Matias & Beveridge identified a possible periplasmic space in S. aureus 
(Matias & Beveridge, 2006), and based on “mathematical analysis” this brings into 
question whether or not the PGP chain of LTA protrudes through the cell wall, as 
depicted in most papers. 
 
The second overall aim of this study was to elucidate how LTA synthesis is 
regulated, by studying how LtaS production is regulated and how LTA and LtaS 
production is affected under stress conditions.  
It was previously found in our laboratory that in two S. aureus strains, RN4220 
and Newman, ltaS has two transcriptional start sites located 408 bp (P1 promoter) and 
294 bp (P2 promoter) in front of the translation start site (Gründling, unpublished 
results). These findings are interesting not only because of the presence of two 
promoters, but also because the second promoter, at 294 bp distance from ltaS initiation 
codon, is still located very far away from the transcriptional start site, resulting in a long 
UTR. The UTR is a non-translated region, in this case upstream of the initiation codon 
(5’UTR or mRNA leader) that contains important regulatory elements (Papenfort & 
Vogel, 2010). Using a deep sequencing-based approach, Irnov and colleagues showed 
that the leader region length in B. subtilis is in average 35 nt long and the authors 
suggest that a likely explanation for a long 5’ mRNA leader region is due to an 
inclusion of a cis-acting regulatory RNA (Irnov et al., 2010). Since the ltaS UTR is 
much longer than the average 35 nt, transcriptional regulation may occur for this gene.  
However, using a bioinformatic approach it was not possible to identify any relevant 
RNA secondary structures, indicating that there may be another regulatory system 
involved. In order to study the relevance of both promoters and of the long UTR, 
different fragments from these regions were cloned upstream of the reporter gene lacZ 
(Figure 13A), which enabled the identification of the fragments able to activate 
expression, based on β-galactosidase activity. From the first set of fusions it was 
possible to see that upon removing the region upstream of the P1 promoter and the P1 
promoter itself, there are still high levels of expression (Figure 13B), which indicated 
that under this experimental conditions the P1 promoter is not needed for expression. 
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Furthermore, no activity was detected following removal of P2 (Figure 13B), indicating 
that this promoter is essential for ltaS expression. 
In order to confirm the relevance of the P2 promoter and investigate the possible 
function for the region between this promoter and the translation start site, further 
fusions to the lacZ gene were constructed (Figure 14A). The results confirmed that 
when ltaS is only under the control of the P1 promoter, there is no expression (Figure 
14B). Furthermore, mutating the P2 promoter specifically indicated that there is no 
expression in its absence and this points to a scenario where the P2 promoter is not only 
sufficient, but also necessary for expression. However, these results do not give any 
information about the role of the P1 promoter, which seems to be irrelevant for 
expression under these conditions. Lastly, by removing the region between the P2 
promoter and the ltaS initiation codon, it was possible to see that lacZ expression was 
not affected. These results pose two questions: why is the P1 promoter present if is not 
necessary for expression and why is there a large distance between the active promoter, 
P2, and ltaS initiation codon, which, as mentioned above, is rarely found. One 
explanation for the region between the -294 bp and the initiation codon could be the 
existence of a second open reading frame (ORF) similar to what was identified in the 
large UTR region of the dlt operon (Koprivnjak et al., 2006), but none have been 
identified using bioinformatic prediction programmes. 
For these assays ltaS expression was only evaluated when cells were in the 
exponential growth phase but these two regions in the UTR may have important roles in 
activation and/or repression of expression during different phases of growth. As shown 
above, LtaS seems to localise at the septum indicating a role in cell division and during 
exponential growth, cell division occurs most rapidly, which may affect ltaS expression 
levels during this phase. Therefore, it could be of interest to evaluate β-galactosidase 
activity of these fusions during different growth phases (lag phase, early exponential 
phase, mid-exponential phase, late exponential phase and stationary phase, for example) 
and in different conditions such as pH, salt concentration and temperature in order to 
look for a possible role for the P1 promoter and the region between the P2 promoter and 
the initiation codon at different phases and conditions. Additionally, it could also be of 
interest to look for possible trans-acting regulator factors like DNA or RNA binding 
proteins that may need a large region to bind to, justifying the large UTR found 
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upstream of ltaS. The possibility of factors being involved in up or down regulation of 
this gene could be further investigated performing a transposon mutant screen. The ltaS 
full-length promoter lacZ fusion could be used to perform this screen in order to 
identify factors up or down regulating ltaS through visual selection on plates containing 
the chromogenic 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal).  
In conclusion, the presence of two promoters upstream of ltaS was identified 
and only the promoter closer to the initiation codon is necessary and sufficient for 
expression. The large region between the active promoter and the initiation codon is not 
necessary to activate expression during exponential phase and so far no role for this 
region has been identified.   
 
Lastly, osmolarity is an important factor for pathogenic bacteria, since 
differences between external and host associated environments, as well as between 
different environments within the host, are associated with variations in expression of 
virulence factors (Chowdhury et al., 1996). Since LTA is important for virulence in S. 
aureus, its production under different osmolarity conditions and how this affects growth 
was assessed by performing growth curves using LB media containing 0% to 6% NaCl 
and western blot analysis to detect LTA and full-length LtaS under these conditions in 
the exponential growth phase. To assess the effect of varying levels of LtaS, both wild-
type and inducible ltaS strains were used, where it is known that even in the presence of 
the inducer, the inducible strains produce reduced amounts of LTA (Wörmann et al., 
2011b). These experiments were intended to evaluate the importance of this polymer 
under high or low osmolarity conditions. It was observed that S. aureus growth rate is 
reduced under high osmolarity in both wild-type and inducible ltaS strains with inducer, 
however the effect was more accentuated in the inducible strains (Figure 15). This was 
observed in both the laboratory S. aureus strain RN4220 and in the MRSA strain LAC*. 
This result could be due to altered LTA levels, consequently having an impact on 
growth under high osmolarity conditions, and so LTA production was assessed by 
western blot analysis. The results obtained indicated that LTA production is reduced 
both in the wild-type and in the inducible ltaS strains with inducer when the salt 
concentration increases and the effect is again more accentuated for the inducible strains 
(Figure 16A). This analysis identified differences between the two S. aureus strains 
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used: while the wild-type RN4220 strain has wild-type levels of LTA when grown with 
5% NaCl, the wild-type LAC* strain showed a decrease in LTA production from 2 to 
3% NaCl, but the growth rate is only reduced at 5% NaCl. This suggests that LTA 
production does not correlate with growth reduction in the strain LAC*.  
In order to determine whether the decrease in LTA synthesis was due to a 
decrease in LtaS production, full-length LtaS production was assessed by western blot. 
This demonstrated that expression of ltaS from the spac promoter was comparable to 
the wild-type strain in both RN4220 and LAC* strains. These results also showed that 
with the increase in salt concentration, full-length LtaS was produced at constant levels 
for both the wild-type and the inducible ltaS strains with inducer (Figure 16B), which 
also excludes the possibility that expression from the spac promoter was affected by the 
increase in salt concentration. Given that LtaS expression remains constant while LTA 
production is reduced, may indicates that there is a decrease in the enzymatic activity of 
the LtaS protein due to an increase in salt concentration, and LTA stability itself may be 
altered under these conditions.  
These results suggest that LTA production and growth are both affected at high 
salt concentrations, while LtaS remains unaffected, indicating that this polymer is 
important to protect cells under high osmolarity conditions. However, this is not in 
accordance with previous data, where it has been shown that at 37°C LTA negative 
strains can only grow under high osmolarity conditions (7.5% NaCl or 40% sucrose) 
suggesting that LTA is more important under low osmolarity conditions (Oku et al., 
2009). Nevertheless it is important to note that this LTA negative mutant was not fully 
sequenced and it is known that suppressor mutations can change the need for LTA to be 
present (Corrigan et al., 2011), which may affect the conclusions drawn from the 
phenotypic analysis of Oku and colleagues. In order to test if LTA it is indeed important 
as an osmoprotectant under low osmolarity conditions the inducible ltaS strain could be 
subjected to an osmotic down shock and the effect in cell death analysed through the 
live/dead assay referred above. Since the inducible strains even with inducer are known 
to produce less LtaS than the wild-type strains (Wörmann et al., 2011b), an osmotic 
down shock could cause an increase in the number of dead cells comparing with the 
wild-type strains because reduced amounts of LTA would make cells more susceptible 
to the osmotic shock. An alternative possibility is that these observations are not due to 
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an osmotic effect, but instead due to an increase in ion concentrations since there are 
more Na
+
 and Cl
-
 ions in solution. This could be assessed by performing similar assays 
using a range of sugar concentrations (sucrose, for example) instead of salt 
concentrations to distinguish between an osmotic or ionic effect.  
In conclusion, it was possible to observe that an increase in NaCl alters the 
growth of S. aureus and also LTA production, but not LtaS production. However, 
whether these observations are due to an osmotic or ionic effect remains unknown.  
 
 This study aimed to give further insights into the roles of LTA and how LTA 
production is regulated under normal growth and stress conditions in S. aureus. It was 
possible to experimentally confirm that LTA is necessary for the efficient incorporation 
of D-alanine residues into WTA, which interconnects the roles of these two polymers 
closely related with their decoration with D-alanine residues. Furthermore, the absence 
of LTA was shown to be lethal resulting in cell membrane depolarisation. LtaS, 
essential for LTA synthesis, was suggested to localise in the cell site division. These 
results confirm that LTA might be a good target for new antimicrobials and highlight 
the multitude of processes for which LTA is important in the cell. Regarding LTA 
regulation, through transcriptional analysis it was shown that there are two promoters 
for ltaS expression and a large upstream UTR region, and although only one promoter 
was shown to be essential and sufficient for transcription, there is still the possibility 
that the other promoter is important under different conditions. Changes in NaCl 
concentration in the media seems to have an effect on LTA production, but not on LtaS 
synthesis, which may indicate an altered enzymatic activity of LtaS caused either by an 
osmotic or ionic effect. Once further elucidated the way LTA production can be 
affected, these can be used as new factors to arrest S. aureus growth.   
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Figure S1 – Full spectra from NMR analysis of WTA isolated from WT and LTA negative S. 
aureus strains. S. aureus strains WT and 4S5 (LTA negative) where grown to mid-log phase and WTA 
purified as described in the Materials and Methods section. Six mg of dried WTA were suspended in 
99.99 % D2O and 1-D proton spectra acquired at 600 MHz. The experiment was performed in triplicate 
and representative full spectra are shown. The ratio of the D-Ala to GlcNAc signal is 0.54 ± 0.08 for 
WTA isolated from a WT strain and 0.11 ± 0.01 for WTA isolated from the LTA negative strain. Peaks 
are annotated as previously described (Bernal et al, 2009).  
 
